Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes

Abarca-Gómez, L.; Abdeen, Z.A.; Hamid, Z.A.; Abu-Rmeileh, N.M.; Acosta-Cazares, B.; Acuin, C.; Adams, R.J.; Aekplakorn, W.; Afsana, K.; Aguilar-Salinas, C.A.; Agyemang, C.; Ahmadvand, A.; Ahrens, W.; Ajlouni, K.; Akhtaeva, N.; Al-Hazzaa, H.M.; Al-Othman, A.R.; Al-Raddadi, R.; Al Buhairan, F.; Al Dhukair, S.; Ali, M.M.; Ali, O.; Alkerwi, A.; Alvarez-Pedrerol, M.; Aly, E.; Amarapurkar, D.N.; Amouyel, P.; Amuzu, A.; Andersen, L.B.; Anderssen, S.A.; Andrade, D.S.; Ängquist, L.H.; Anjana, R.M.; Aounallah-Skhiri, H.; Araújo, J.; Ariansen, I.; Aris, T.; Arlappa, N.; Arveiler, D.; Aryal, K.K.; Aspelund, T.; Assah, F.K.; Assunção, M.C.F.; Aung, M.S.; Avdicová, M.; Azevedo, A.; Azizi, F.; Babu, B.V.; Bahijri, S.; Baker, J.L.; Balakrishna, N.; Bamoshmoosh, M.; Banach, M.; Bandosz, P.; Banegas, J.R.; Barbagallo, C.M.; Barceló, A.; Barkat, A.; Barros, A.J.D.; Barros, M.V.G.; Bata, I.; Batieha, A.M.; Batista, R.L.; Batyrbek, A.; Baur, L.A.; Beaglehole, R.; Romdhane, H.B.; Benedics, J.; Benet, M.; Bennett, J.E.; Bernabe-Ortiz, A.; Bernotiene, G.; Bettiol, H.; Bhagyalaxmi, A.; Bharadwaj, S.; Bhargava, S.K.; Bhatti, Z.; Bhutta, Z.A.; Bi, H.; Bi, Y.; Biehl, A.; Bikbov, M.; Bista, B.; Bjelica, D.J.; Bjerregaard, P.; Bjertness, E.; Bjertness, M.B.; Björkelund, C.; Blokstra, A.; Bo, S.; Bobak, M.; Boddy, L.M.; Boehm, B.O.; Boeing, H.; Boggia, J.G.; Boissonnet, C.P.; Bonaccio, M.; Bongard, V.; Bovet, P.; Braeckevelt, L.; Braeckman, L.; Bragt, M.C.E.; Brajkovich, I.; Branca, F.; Breckenkamp, J.; Breda, J.; Brenner, H.; Brewster, L.M.; Brian, G.R.; Brinduse, L.; Bruno, G.; Bueno-de-Mesquita, H.B.; Bugge, A.; Buoncristiano, M.; Burazeri, G.; Burns, C.; de León, A.C.; Cacciottolo, J.; Cai, H.; Cama, T.; Cameron, C.; Camolas, J.; Can, G.; Cândido, A.P.C.; Capanzana, M.; Capuano, V.; Cardoso, V.C.; Carlsson, A.C.; Carvalho, M.J.; Casanueva, F.F.; Casas, J-P.; Caserta, C.A.; Chamukuttan, S.; Chan, A.W.; Chan, Q.; Chaturvedi, H.K.; Chaturvedi, N.; Chen, C-J.; Chen, F.; Chen, H.; Chen, S.; Chen, Z.; Cheng, C-Y.; Chetrit, A.; Chikova-Iscener, E.; Chiolero, A.; Chiou, S-T.; Chirita-Emandi, A.; Chirlaque, M-D.; Cho, B.; Cho, Y.; Christensen, K.; Christofaro, D.G.; Chudek, J.; Cifkova, R.; Cinteza, E.; Claessens, F.; Clays, E.; Concin, H.; Confortin, S.C.; Cooper, C.; Cooper, R.; Coppinger, T.C.; Costanzo, S.; Cottel, D.; Cowell, C.; Craig, C.L.; Crujeiras, A.B.; Cucu, A.; D’Arrigo, G.; d’Orsi, E.; Dallongeville, J.; Damasceno, A.; Damsgaard, C.T.; Danaei, G.; Dankner, R.; Dantoft, T.M.; Dastgiri, S.; Dauchet, L.; Davletov, K.; De Backer, G.; De Bacquer, D.; De Curtis, A.; de Gaetano, G.; De Henauw, S.; de Oliveira, P.D.; De Ridder, K.; De Smedt, D.; Deepa, M.; Deev, A.D.; Dehghan, A.; Delisle, H.; Delpeuch, F.; Deschamps, V.; Dhana, K.; Di Castelnuovo, A.F.; Dias-da-Costa, J.S.; Diaz, A.; Dika, Z.; Djalalinia, S.; Do, H.T.P.; Dobson, A.J.; Donati, M.B.; Donfrancesco, C.; Donoso, S.P.; Döring, A.; Dorobantu, M.; Dorosty, A.R.; Doua, K.; Drygas, W.; Duan, J.L.; Duante, C.; Duleva, V.; Dulskiene, V.; Dzerve, V.; Dziankowska-Zaborszczyk, E.; Egbagbe, E.E.; Eggertsen, R.; Eiben, G.; Ekelund, U.; El Ati, J.; Elliott, P.; Engle-Stone, R.; Erasmus, R.T.; Erem, C.; Eriksen, L.; Eriksson, J.G.; la Peña, J.E.; Evans, A.; Faeh, D.; Fall, C.H.; Sant’Angelo, V.F.; Farzadfar, F.; Felix-Redondo, F.J.; Ferguson, T.S.; Fernandes, R.A.; Fernández-Bergés, D.; Ferrante, D.; Ferrari, M.; Ferreccio, C.; Ferrieres, J.; Finn, J.D.; Fischer, K.; Flores, E.M.; Föger, B.; Foo, L.H.; Forslund, A-S.; Forsner, M.; Fouad, H.M.; Francis, D.K.; Franco, M.C.; Franco, O.H.; Frontera, G.; Fuchs, F.D.; Fuchs, S.C.; Fujita, Y.; Furusawa, T.; Gaciong, Z.; Gafencu, M.; Galeone, D.; Galvano, F.; Garcia-de-la-Hera, M.; Gareta, D.; Garnett, S.P.; Gaspoz, J-M.; Gasull, M.; Gates, L.; Geiger, H.; Geleijnse, J.M.; Ghasemian, A.; Giampaoli, S.; Gianfagna, F.; Gill, T.K.; Giovannelli, J.; Giwercman, A.; Godos, J.; Gogen, S.; Goldsmith, R.A.; Goltzman, D.; Gonçalves, H.; González-Leon, M.; González-Rivas, J.P.; Gonzalez-Gross, M.; Gottrand, F.; Graça, A.P.; Graff-Iversen, S.; Grafnetter, D.; Grajda, A.; Grammatikopoulou, M.G.; Gregor, R.D.; Grodzicki, T.; Grøntved, A.; Grosso, G.; Gruden, G.; Grujic, V.; Gu, D.; Gualdi-Russo, E.; Guallar-Castillón, P.; Guan, O.P.; Gudmundsson, E.F.; Gudnason, V.; Guerrero, R.; Guessous, I.; Guimaraes, A.L.; Gulliford, M.C.; Gunnlaugsdottir, J.; Gunter, M.; Guo, X.; Guo, Y.; Gupta, P.C.; Gupta, R.; Gureje, O.; Gurzkowska, B.; Gutierrez, L.; Gutzwiller, F.; Hadaegh, F.; Hadjigeorgiou, C.A.; Si-Ramlee, K.; Halkjær, J.; Hambleton, I.R.; Hardy, R.; Kumar, R.H.; Hassapidou, M.; Hata, J.; Hayes, A.J.; He, J.; Heidinger-Felso, R.; Heinen, M.; Hendriks, M.E.; Henriques, A.; Cadena, L.H.; Herrala, S.; Herrera, V.M.; Herter-Aeberli, I.; Heshmat, R.; Hihtaniemi, I.T.; Ho, S.Y.; Ho, S.C.; Hobbs, M.; Hofman, A.; Hopman, W.M.; Horimoto, A.R.V.R.; Hormiga, C.M.; Horta, B.L.; Houti, L.; Howitt, C.; Htay, T.T.; Htet, A.S.; Htike, M.M.T.; Hu, Y.; Huerta, J.M.; Petrescu, C.H.; Huisman, M.; Husseini, A.; Huu, C.N.; Huybrechts, I.; Hwalla, N.; Hyska, J.; Iacoviello, L.; Iannone, A.G.; Ibarluzea, J.M.; Ibrahim, M.M.; Ikeda, N.; Ikram, M.A.; Irazola, V.E.; Islam, M.; Ismail, A-S.; Ivkovic, V.; Iwasaki, M.; Jackson, R.T.; Jacobs, J.M.; Jaddou, H.; Jafar, T.; Jamil, K.M.; Jamrozik, K.; Janszky, I.; Jarani, J.; Jasienska, G.; Jelakovic, A.; Jelakovic, B.; Jennings, G.; Jeong, S-L.; Jiang, C.Q.; Jiménez-Acosta, S.M.; Joffres, M.; Johansson, M.; Jonas, J.B.; Jørgensen, T.; Joshi, P.; Jovic, D.P.; Józwiak, J.; Juolevi, A.; Jurak, G.; Jureša, V.; Kaaks, R.; Kafatos, A.; Kajantie, E.O.; Kalter-Leibovici, O.; Kamaruddin, N.A.; Kapantais, E.; Karki, K.B.; Kasaeian, A.; Katz, J.; Kauhanen, J.; Kaur, P.; Kavousi, M.; Kazakbaeva, G.; Keil, U.; Boker, L.K.; Keinänen-Kiukaanniemi, S.; Kelishadi, R.; Kelleher, C.; Kemper, H.C.G.; Kengne, A.P.; Kerimkulova, A.; Kersting, M.; Key, T.; Khader, Y.S.; Khalili, D.; Khang, Y-H.; Khateeb, M.; Khaw, K-T.; Khouw, I.M.S.L.; Kiechl-Kohlendorfer, U.; Kiechl, S.; Killewo, J.; Kim, J.; Kim, Y-Y.; Klimont, J.; Klumbiene, J.; Knoflach, M.; Koirala, B.; Kolle, E.; Kolsteren, P.; Korrovits, P.; Kos, J.; Koskinen, S.; Kouda, K.; Kovacs, V.A.; Kowlessur, S.; Koziel, S.; Kratzer, W.; Kriemler, S.; Kristensen, P.L.; Krokstad, S.; Kromhout, D.; Kruger, H.S.; Kubinova, R.; Kuciene, R.; Kuh, D.; Kujala, U.M.; Kulaga, Z.; Kumar, R.K.; Kunešová, M.; Kurjata, P.; Kusuma, Y.S.; Kuulasmaa, K.; Kyobutungi, C.; La, Q.N.; Laamiri, F.Z.; Laatikainen, T.; Lachat, C.; Laid, Y.; Lam, T.H.; Landrove, O.; Lanska, V.; Lappas, G.; Larijani, B.; Laugsand, L.E.; Lauria, L.; Laxmaiah, A.; Bao, K.L.N.; Le, T.D.; Lebanan, M.A.O.; Leclercq, C.; Lee, J.; Lee, J.; Lehtimäki, T.; León-Muñoz, L.M.; Levitt, N.S.; Li, Y.; Lilly, C.L.; Lim, W-Y.; Lima-Costa, M.F.; Lin, H-H.; Lin, X.; Lind, L.; Linneberg, A.; Lissner, L.; Litwin, M.; Liu, J.; Loit, H-M.; Lopes, L.; Lorbeer, R.; Lotufo, P.A.; Lozano, J.E.; Luksiene, D.; Lundqvist, A.; Lunet, N.; Lytsy, P.; Ma, G.; Ma, J.; Machado-Coelho, G.L.L.; Machado-Rodrigues, A.M.; Machi, S.; Maggi, S.; Magliano, D.J.; Magriplis, E.; Mahaletchumy, A.; Maire, B.; Majer, M.; Makdisse, M.; Malekzadeh, R.; Malhotra, R.; Rao, K.M.; Malyutina, S.; Manios, Y.; Mann, J.I.; Manzato, E.; Margozzini, P.; Markaki, A.; Markey, O.; Marques, L.P.; Marques-Vidal, P.; Marrugat, J.; Martin-Prevel, Y.; Martin, R.; Martorell, R.; Martos, E.; Marventano, S.; Masoodi, S.R.; Mathiesen, E.B.; Matijasevich, A.; Matsha, T.E.; Mazur, A.; Mbanya, J.C.N.; McFarlane, S.R.; McGarvey, S.T.; McKee, M.; McLachlan, S.; McLean, R.M.; McLean, S.B.; McNulty, B.A.; Yusof, S.M.; Mediene-Benchekor, S.; Medzioniene, J.; Meirhaeghe, A.; Meisfjord, J.; Meisinger, C.; Menezes, A.M.B.; Menon, G.R.; Mensink, G.B.M.; Meshram, I.I.; Metspalu, A.; Meyer, H.E.; Mi, J.; Michaelsen, K.F.; Michels, N.; Mikkel, K.; Miller, J.C.; Minderico, C.S.; Miquel, J.F.; Miranda, J.J.; Mirkopoulou, D.; Mirrakhimov, E.; Mišigoj-Durakovic, M.; Mistretta, A.; Mocanu, V.; Modesti, P.A.; Mohamed, M.K.; Mohammad, K.; Mohammadifard, N.; Mohan, V.; Mohanna, S.; Yusoff, M.F.M.; Molbo, D.; Møllehave, L.T.; Møller, N.C.; Molnár, D.; Momenan, A.; Mondo, C.K.; Monterrubio, E.A.; Monyeki, K.D.K.; Moon, J.S.; Moreira, L.B.; Morejon, A.; Moreno, L.A.; Morgan, K.; Mortensen, E.L.; Moschonis, G.; Mossakowska, M.; Mostafa, A.; Mota, J.; Mota-Pinto, A.; Motlagh, M.E.; Motta, J.; Mu, T.T.; Muc, M.; Muiesan, M.L.; Müller-Nurasyid, M.; Murphy, N.; Mursu, J.; Murtagh, E.M.; Musil, V.; Nabipour, I.; Nagel, G.; Naidu, B.M.; Nakamura, H.; Námešná, J.; Nang, E.E.K.; Nangia, V.B.; Nankap, M.; Narake, S.; Nardone, P.; Navarrete-Muñoz, E.M.; Neal, W.A.; Nenko, I.; Neovius, M.; Nervi, F.; Nguyen, C.T.; Nguyen, N.D.; Nguyen, Q.N.; Nieto-Martínez, R.E.; Ning, G.; Ninomiya, T.; Nishtar, S.; Noale, M.; Noboa, O.A.; Norat, T.; Norie, S.; Noto, D.; Nsour, M.A.; O’Reilly, D.; Obreja, G.; Oda, E.; Oehlers, G.; Oh, K.; Ohara, K.; Olafsson, Ö.; Olinto, M.T.A.; Oliveira, I.O.; Oltarzewski, M.; Omar, M.A.; Onat, A.; Ong, S.K.; Ono, L.M.; Ordunez, P.; Ornelas, R.; Ortiz, A.P.; Osler, M.; Osmond, C.; Ostojic, S.M.; Ostovar, A.; Otero, J.A.; Overvad, K.; Owusu-Dabo, E.; Paccaud, F.M.; Padez, C.; Pahomova, E.; Pajak, A.; Palli, D.; Palloni, A.; Palmieri, L.; Pan, W-H.; Panda-Jonas, S.; Pandey, A.; Panza, F.; Papandreou, D.; Park, S-W.; Parnell, W.R.; Parsaeian, M.; Pascanu, I.M.; Patel, N.D.; Pecin, I.; Pednekar, M.S.; Peer, N.; Peeters, P.H.; Peixoto, S.V.; Peltonen, M.; Pereira, A.C.; Perez-Farinos, N.; Pérez, C.M.; Peters, A.; Petkeviciene, J.; Petrauskiene, A.; Peykari, N.; Pham, S.T.; Pierannunzio, D.; Pigeot, I.; Pikhart, H.; Pilav, A.; Pilotto, L.; Pistelli, F.; Pitakaka, F.; Piwonska, A.; Plans-Rubió, P.; Poh, B.K.; Pohlabeln, H.; Pop, R.M.; Popovic, S.R.; Porta, M.; Portegies, M.L.P.; Posch, G.; Poulimeneas, D.; Pouraram, H.; Pourshams, A.; Poustchi, H.; Pradeepa, R.; Prashant, M.; Price, J.F.; Puder, J.J.; Pudule, I.; Puiu, M.; Punab, M.; Qasrawi, R.F.; Qorbani, M.; Bao, T.Q.; Radic, I.; Radisauskas, R.; Rahman, M.; Rahman, M.; Raitakari, O.; Raj, M.; Rao, S.R.; Ramachandran, A.; Ramke, J.; Ramos, E.; Ramos, R.; Rampal, L.; Rampal, S.; Rascon-Pacheco, R.A.; Redon, J.; Reganit, P.F.M.; Ribas-Barba, L.; Ribeiro, R.; Riboli, E.; Rigo, F.; de Wit, T.F.R.; Rito, A.; Ritti-Dias, R.M.; Rivera, J.A.; Robinson, S.M.; Robitaille, C.; Rodrigues, D.; Rodríguez-Artalejo, F.; del Cristo Rodriguez-Perez, M.; Rodríguez-Villamizar, L.A.; Rojas-Martinez, R.; Rojroongwasinkul, N.; Romaguera, D.; Ronkainen, K.; Rosengren, A.; Rouse, I.; Roy, J.G.R.; Rubinstein, A.; Rühli, F.J.; Ruiz-Betancourt, B.S.; Russo, P.; Rutkowski, M.; Sabanayagam, C.; Sachdev, H.S.; Saidi, O.; Salanave, B.; Martinez, E.S.; Salmerón, D.; Salomaa, V.; Salonen, J.T.; Salvetti, M.; Sánchez-Abanto, J.; Sandjaja; Sans, S.; Marina, L.S.; Santos, D.A.; Santos, I.S.; Santos, O.; dos Santos, R.N.; Santos, R.; Saramies, J.L.; Sardinha, L.B.; Sarrafzadegan, N.; Saum, K-U.; Savva, S.; Savy, M.; Scazufca, M.; Rosario, A.S.; Schargrodsky, H.; Schienkiewitz, A.; Schipf, S.; Schmidt, C.O.; Schmidt, I.M.; Schultsz, C.; Schutte, A.E.; Sein, A.A.; Sen, A.; Senbanjo, I.O.; Sepanlou, S.G.; Serra-Majem, L.; Shalnova, S.A.; Sharma, S.K.; Shaw, J.E.; Shibuya, K.; Shin, D.W.; Shin, Y.; Shiri, R.; Siani, A.; Siantar, R.; Sibai, A.M.; Silva, A.M.; Silva, D.A.S.; Simon, M.; Simons, J.; Simons, L.A.; Sjöberg, A.; Sjöström, M.; Skovbjerg, S.; Slowikowska-Hilczer, J.; Slusarczyk, P.; Smeeth, L.; Smith, M.C.; Snijder, M.B.; So, H-K.; Sobngwi, E.; Söderberg, S.; Soekatri, M.Y.E.; Solfrizzi, V.; Sonestedt, E.; Song, Y.; Sørensen, T.I.A.; Soric, M.; Jérome, C.S.; Soumare, A.; Spinelli, A.; Spiroski, I.; Staessen, J.A.; Stamm, H.; Starc, G.; Stathopoulou, M.G.; Staub, K.; Stavreski, B.; Steene-Johannessen, J.; Stehle, P.; Stein, A.D.; Stergiou, G.S.; Stessman, J.; Stieber, J.; Stöckl, D.; Stocks, T.; Stokwiszewski, J.; Stratton, G.; Stronks, K.; Strufaldi, M.W.; Suárez-Medina, R.; Sun, C-A.; Sundström, J.; Sung, Y-T.; Sunyer, J.; Suriyawongpaisal, P.; Swinburn, B.A.; Sy, R.G.; Szponar, L.; Tai, E.S.; Tammesoo, M-L.; Tamosiunas, A.; Tan, E.J.; Tang, X.; Tanser, F.; Tao, Y.; Tarawneh, M.R.; Tarp, J.; Tarqui-Mamani, C.B.; Tautu, O-F.; Braunerová, R.T.; Taylor, A.; Tchibindat, F.; Theobald, H.; Theodoridis, X.; Thijs, L.; Thuesen, B.H.; Tjonneland, A.; Tolonen, H.K.; Tolstrup, J.S.; Topbas, M.; Topór-Madry, R.; Tormo, M.J.; Tornaritis, M.J.; Torrent, M.; Toselli, S.; Traissac, P.; Trichopoulos, D.; Trichopoulou, A.; Trinh, O.T.H.; Trivedi, A.; Tshepo, L.; Tsigga, M.; Tsugane, S.; Tulloch-Reid, M.K.; Tullu, F.; Tuomainen, T-P.; Tuomilehto, J.; Turley, M.L.; Tynelius, P.; Tzotzas, T.; Tzourio, C.; Ueda, P.; Ugel, E.E.; Ukoli, F.A.M.; Ulmer, H.; Unal, B.; Uusitalo, H.M.T.; Valdivia, G.; Vale, S.; Valvi, D.; van der Schouw, Y.T.; Van Herck, K.; Van Minh, H.; van Rossem, L.; Van Schoor, N.M.; van Valkengoed, I.G.M.; Vanderschueren, D.; Vanuzzo, D.; Vatten, L.; Vega, T.; Veidebaum, T.; Velasquez-Melendez, G.; Velika, B.; Veronesi, G.; Verschuren, W.M.M.; Victora, C.G.; Viegi, G.; Viet, L.; Viikari-Juntura, E.; Vineis, P.; Vioque, J.; Virtanen, J.K.; Visvikis-Siest, S.; Viswanathan, B.; Vlasoff, T.; Vollenweider, P.; Völzke, H.; Voutilainen, S.; Vrijheid, M.; Wade, A.N.; Wagner, A.; Waldhör, T.; Walton, J.; Bebakar, W.M.W.; Mohamud, W.N.W.; Wanderley, R.S., Jr; Wang, M-D.; Wang, Q.; Wang, Y.X.; Wang, Y-W.; Wannamethee, S.G.; Wareham, N.; Weber, A.; Wedderkopp, N.; Weerasekera, D.; Whincup, P.H.; Widhalm, K.; Widyahening, I.S.; Wiecek, A.; Wijga, A.H.; Wilks, R.J.; Willeit, J.; Willeit, P.; Wilsgaard, T.; Wojtyniak, B.; Wong-McClure, R.A.; Wong, J.Y.Y.; Wong, J.E.; Wong, T.Y.; Woo, J.; Woodward, M.; Wu, F.C.; Wu, J.; Wu, S.; Xu, H.; Xu, L.; Yamborisut, U.; Yan, W.; Yang, X.; Yardim, N.; Ye, X.; Yiallouros, P.K.; Yngve, A.; Yoshihara, A.; You, Q.S.; Younger-Coleman, N.O.; Yusoff, F.; Yusoff, M.F.M.; Zaccagni, L.; Zafiropulos, V.; Zainuddin, A.A.; Zambon, S.; Zampelas, A.; Zamrazilová, H.; Zdrojewski, T.; Zeng, Y.; Zhao, D.; Zhao, W.; Zheng, W.; Zheng, Y.; Zholdin, B.; Zhou, M.; Zhu, D.; Zhussupov, B.; Zimmermann, E.; Cisneros, J.Z.; Bentham, J.; Di Cesare, M.; Bilano, V.; Bixby, H.; Zhou, B.; Stevens, G.A.; Riley, L.M.; Taddei, C.; Hajifathalian, K.; Lu, Y.; Savin, S.; Cowan, M.J.; Paciorek, C.J.; Chirita-Emandi, A.; Hayes, A.J.; Katz, J.; Kelishadi, R.; Kengne, A.P.; Khang, Y-H.; Laxmaiah, A.; Li, Y.; Ma, J.; Miranda, J.J.; Mostafa, A.; Neovius, M.; Padez, C.; Rampal, L.; Zhu, A.; Bennett, J.E.; Danaei, G.; Bhutta, Z.A.; Ezzati, M. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet, 2017, 390(10113), 2627-2642.
[http://dx.doi.org/10.1016/S0140-6736(17)32129-3] [PMID: 29029897]

Andes, L.J.; Cheng, Y.J.; Rolka, D.B.; Gregg, E.W.; Imperatore, G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005-2016. JAMA Pediatr., 2020, 174(2), e194498.
[http://dx.doi.org/10.1001/jamapediatrics.2019.4498] [PMID: 31790544]

ElSayed, N.A.; Aleppo, G.; Bannuru, R.R.; Bruemmer, D.; Collins, B.S.; Ekhlaspour, L.; Gaglia, J.L.; Hilliard, M.E.; Johnson, E.L.; Khunti, K.; Lingvay, I.; Matfin, G.; McCoy, R.G.; Perry, M.L.; Pilla, S.J.; Polsky, S.; Prahalad, P.; Pratley, R.E.; Segal, A.R.; Seley, J.J.; Selvin, E.; Stanton, R.C.; Gabbay, R.A. 2. Diagnosis and classification of diabetes: Standards of care in diabetes—2024. Diabetes Care, 2024, 47(S1), S20-S42.
[http://dx.doi.org/10.2337/dc24-S002] [PMID: 38078589]

Hostalek, U. Global epidemiology of prediabetes - Present and future perspectives. Clin. Diabetes Endocrinol., 2019, 5(1), 5.
[http://dx.doi.org/10.1186/s40842-019-0080-0] [PMID: 31086677]

Wang, L.; Gao, P.; Zhang, M.; Huang, Z.; Zhang, D.; Deng, Q.; Li, Y.; Zhao, Z.; Qin, X.; Jin, D.; Zhou, M.; Tang, X.; Hu, Y.; Wang, L. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA, 2017, 317(24), 2515-2523.
[http://dx.doi.org/10.1001/jama.2017.7596] [PMID: 28655017]

Karve, A.; Hayward, R.A. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care, 2010, 33(11), 2355-2359.
[http://dx.doi.org/10.2337/dc09-1957] [PMID: 20724649]

Cai, X.; Zhang, Y.; Li, M.; Wu, J.H.Y.; Mai, L.; Li, J.; Yang, Y.; Hu, Y.; Huang, Y. Association between prediabetes and risk of all cause mortality and cardiovascular disease: Updated meta-analysis. BMJ, 2020, 370, m2297.
[http://dx.doi.org/10.1136/bmj.m2297] [PMID: 32669282]

ElSayed, N.A.; Aleppo, G.; Bannuru, R.R.; Bruemmer, D.; Collins, B.S.; Ekhlaspour, L.; Gaglia, J.L.; Hilliard, M.E.; Johnson, E.L.; Khunti, K.; Lingvay, I.; Matfin, G.; McCoy, R.G.; Perry, M.L.; Pilla, S.J.; Polsky, S.; Prahalad, P.; Pratley, R.E.; Segal, A.R.; Seley, J.J.; Selvin, E.; Stanton, R.C.; Gabbay, R.A. 3. Prevention or delay of diabetes and associated comorbidities: Standards of care in diabetes—2024. Diabetes Care, 2024, 47(S1), S43-S51.
[http://dx.doi.org/10.2337/dc24-S003] [PMID: 38078581]

Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 2002, 346(6), 393-403.
[http://dx.doi.org/10.1056/NEJMoa012512] [PMID: 11832527]

Rooney, M.R.; Rawlings, A.M.; Pankow, J.S.; Echouffo Tcheugui, J.B.; Coresh, J.; Sharrett, A.R.; Selvin, E. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern. Med., 2021, 181(4), 511-519.
[http://dx.doi.org/10.1001/jamainternmed.2020.8774] [PMID: 33555311]

Ligthart, S.; van Herpt, T.T.W.; Leening, M.J.G.; Kavousi, M.; Hofman, A.; Stricker, B.H.C.; van Hoek, M.; Sijbrands, E.J.G.; Franco, O.H.; Dehghan, A. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: A prospective cohort study. Lancet Diabetes Endocrinol., 2016, 4(1), 44-51.
[http://dx.doi.org/10.1016/S2213-8587(15)00362-9] [PMID: 26575606]

Souza, C.F.; Gross, J.L.; Gerchman, F.; Leitão, C.B. Prediabetes: Diagnosis, evaluation of chronic complications, and treatment. Arq. Bras. Endocrinol. Metabol, 2012, 56(5), 275-284.
[http://dx.doi.org/10.1590/S0004-27302012000500001] [PMID: 22911279]

Schlesinger, S.; Neuenschwander, M.; Barbaresko, J.; Lang, A.; Maalmi, H.; Rathmann, W.; Roden, M.; Herder, C. Prediabetes and risk of mortality, diabetes-related complications and comorbidities: Umbrella review of meta-analyses of prospective studies. Diabetologia, 2022, 65(2), 275-285.
[http://dx.doi.org/10.1007/s00125-021-05592-3] [PMID: 34718834]

Farrell, C.; Moran, J. Comparison of comorbidities in patients with pre-diabetes to those with diabetes mellitus type 2. Ir. Med. J., 2014, 107(3), 72-74.
[PMID: 24757888]

American Diabetes Association Professional Practice Committee. 3. Prevention or delay of type 2 diabetes and associated comorbidities: Standards of Medical Care in Diabetes—2022. Diabetes Care, 2022, 45(S1), S39-S45.
[PMID: 34964876]

Lingvay, I.; Sumithran, P.; Cohen, R.V.; le Roux, C.W. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet, 2022, 399(10322), 394-405.
[http://dx.doi.org/10.1016/S0140-6736(21)01919-X] [PMID: 34600604]

Stokes, A.; Collins, J.M.; Grant, B.F.; Scamuffa, R.F.; Hsiao, C.W.; Johnston, S.S.; Ammann, E.M.; Manson, J.E.; Preston, S.H. Obesity progression between young adulthood and midlife and incident diabetes: A retrospective cohort study of U.S. adults. Diabetes Care, 2018, 41(5), 1025-1031.
[http://dx.doi.org/10.2337/dc17-2336] [PMID: 29506982]

Malone, J.I.; Hansen, B.C. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr. Diabetes, 2019, 20(1), 5-9.
[http://dx.doi.org/10.1111/pedi.12787] [PMID: 30311716]

Boden, G.; Homko, C.; Barrero, C.A.; Stein, T.P.; Chen, X.; Cheung, P.; Fecchio, C.; Koller, S.; Merali, S. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Sci. Transl. Med., 2015, 7(304), 304re7.
[http://dx.doi.org/10.1126/scitranslmed.aac4765] [PMID: 26355033]

Borghi, V.C.; Wajchenberg, B.L.; Cesar, F.P. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance. Metabolism, 1984, 33(12), 1068-1074.
[http://dx.doi.org/10.1016/0026-0495(84)90089-1] [PMID: 6390086]

Thiebaud, D.; Jacot, E.; Defronzo, R.A.; Maeder, E.; Jequier, E.; Felber, J.P. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes, 1982, 31(11), 957-963.
[http://dx.doi.org/10.2337/diacare.31.11.957] [PMID: 6757014]

Saltiel, A.R.; Olefsky, J.M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest., 2017, 127(1), 1-4.
[http://dx.doi.org/10.1172/JCI92035] [PMID: 28045402]

Cnop, M.; Toivonen, S.; Esteve, I.M.; Salpea, P. Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells. Mol. Metab., 2017, 6(9), 1024-1039.
[http://dx.doi.org/10.1016/j.molmet.2017.06.001] [PMID: 28951826]

Efrat, S. Beta-Cell dedifferentiation in type 2 diabetes: Concise review. Stem Cells, 2019, 37(10), 1267-1272.
[http://dx.doi.org/10.1002/stem.3059] [PMID: 31298804]

Thomsen, S.K.; Ceroni, A.; van de Bunt, M.; Burrows, C.; Barrett, A.; Scharfmann, R.; Ebner, D.; McCarthy, M.I.; Gloyn, A.L. Systematic functional characterization of candidate causal genes for type 2 diabetes risk variants. Diabetes, 2016, 65(12), 3805-3811.
[http://dx.doi.org/10.2337/db16-0361] [PMID: 27554474]

Linnemann, A.K.; Baan, M.; Davis, D.B. Pancreatic β-cell proliferation in obesity. Adv. Nutr., 2014, 5(3), 278-288.
[http://dx.doi.org/10.3945/an.113.005488] [PMID: 24829474]

Collins, F. Opening keynote: Omics data paves the way for more precise research into variances within diabetes. 2023. Available from: https://www.adameetingnews.org/live-updates/session-coverage/opening-keynote-omics-data-paves-the-way-for-more-precise-research-into-variances-within-diabetes/

Xue, D.; Narisu, N.; Taylor, D.L.; Zhang, M.; Grenko, C.; Taylor, H.J.; Yan, T.; Tang, X.; Sinha, N.; Zhu, J.; Vandana, J.J.; Nok Chong, A.C.; Lee, A.; Mansell, E.C.; Swift, A.J.; Erdos, M.R.; Zhong, A.; Bonnycastle, L.L.; Zhou, T.; Chen, S.; Collins, F.S. Functional interrogation of twenty type 2 diabetes-associated genes using isogenic human embryonic stem cell-derived β-like cells. Cell Metab., 2023, 35(11), 1897-1914.e11.
[http://dx.doi.org/10.1016/j.cmet.2023.09.013] [PMID: 37858332]

Martín-Peláez, S.; Fito, M.; Castaner, O. Mediterranean diet effects on type 2 diabetes prevention, disease progression, and related mechanisms. A review. Nutrients, 2020, 12(8), 2236.
[http://dx.doi.org/10.3390/nu12082236] [PMID: 32726990]

Visseren, F.L.J.; Mach, F.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Bäck, M.; Benetos, A.; Biffi, A.; Boavida, J.M.; Capodanno, D.; Cosyns, B.; Crawford, C.; Davos, C.H.; Desormais, I.; Di Angelantonio, E.; Franco, O.H.; Halvorsen, S.; Hobbs, F.D.R.; Hollander, M.; Jankowska, E.A.; Michal, M.; Sacco, S.; Sattar, N.; Tokgozoglu, L.; Tonstad, S.; Tsioufis, K.P.; van Dis, I.; van Gelder, I.C.; Wanner, C.; Williams, B.; De Backer, G.; Zagrosek, R.V.; Aamodt, A.H.; Abdelhamid, M.; Aboyans, V.; Albus, C.; Asteggiano, R.; Bäck, M.; Borger, M.A.; Brotons, C.; Čelutkienė, J.; Cifkova, R.; Cikes, M.; Cosentino, F.; Dagres, N.; De Backer, T.; De Bacquer, D.; Delgado, V.; Den Ruijter, H.; Dendale, P.; Drexel, H.; Falk, V.; Fauchier, L.; Ference, B.A.; Ferrières, J.; Ferrini, M.; Fisher, M.; Fliser, D.; Fras, Z.; Gaita, D.; Giampaoli, S.; Gielen, S.; Graham, I.; Jennings, C.; Jorgensen, T.; Kautzky-Willer, A.; Kavousi, M.; Koenig, W.; Konradi, A.; Kotecha, D.; Landmesser, U.; Lettino, M.; Lewis, B.S.; Linhart, A.; Løchen, M-L.; Makrilakis, K.; Mancia, G.; Marques-Vidal, P.; McEvoy, J.W.; McGreavy, P.; Merkely, B.; Neubeck, L.; Nielsen, J.C.; Perk, J.; Petersen, S.E.; Petronio, A.S.; Piepoli, M.; Pogosova, N.G.; Prescott, E.I.B.; Ray, K.K.; Reiner, Z.; Richter, D.J.; Rydén, L.; Shlyakhto, E.; Sitges, M.; Sousa-Uva, M.; Sudano, I.; Tiberi, M.; Touyz, R.M.; Ungar, A.; Verschuren, W.M.M.; Wiklund, O.; Wood, D.; Zamorano, J.L.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Bäck, M.; Benetos, A.; Biffi, A.; Boavida, J-M.; Capodanno, D.; Cosyns, B.; Crawford, C.A.; Davos, C.H.; Desormais, I.; Angelantonio, D.E.; Duran, F.O.H.; Halvorsen, S.; Hobbs, R.F.D.; Hollander, M.; Jankowska, E.A.; Michal, M.; Sacco, S.; Sattar, N.; Tokgozoglu, L.; Tonstad, S.; Tsioufis, K.P.; Dis, I.; van Gelder, I.C.; Wanner, C.; Williams, B. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J., 2021, 42(34), 3227-3337.
[http://dx.doi.org/10.1093/eurheartj/ehab484] [PMID: 34458905]

Gong, Q.; Zhang, P.; Wang, J.; Ma, J.; An, Y.; Chen, Y.; Zhang, B.; Feng, X.; Li, H.; Chen, X.; Cheng, Y.J.; Gregg, E.W.; Hu, Y.; Bennett, P.H.; Li, G.; Qian, X.; Zhang, L.; Hui, Y.; He, S.; Wang, X.; Thompson, T.J.; Gerzoff, R.B.; Liu, P.; Jiang, Y.; Hu, Z.; Wang, J.; Jiang, X.; Zhang, J.; Xi, R.; Pang, C.; Li, C.; Hu, X.; Yang, W.; An, Z.; Sun, X.; Chen, C.; Gang, Y.; Liu, J.; Xiao, J.; Cao, H.; Zheng, H.; Zhang, H.; Li, H.; Hong, J.; Liu, X.; Zhao, F.; Wang, W.; Chen, B.; Howard, B.V.; Engelgau, M.M.; Roglic, G. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the da qing diabetes prevention outcome study. Lancet Diabetes Endocrinol., 2019, 7(6), 452-461.
[http://dx.doi.org/10.1016/S2213-8587(19)30093-2] [PMID: 31036503]

Tuomilehto, J.; Lindström, J.; Eriksson, J.G.; Valle, T.T.; Hämäläinen, H.; Parikka, I.P.; Kiukaanniemi, K.S.; Laakso, M.; Louheranta, A.; Rastas, M.; Salminen, V.; Aunola, S.; Cepaitis, Z.; Moltchanov, V.; Hakumäki, M.; Mannelin, M.; Martikkala, V.; Sundvall, J.; Uusitupa, M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med., 2001, 344(18), 1343-1350.
[http://dx.doi.org/10.1056/NEJM200105033441801] [PMID: 11333990]

Redman, L.M.; Heilbronn, L.K.; Martin, C.K.; de Jonge, L.; Williamson, D.A.; Delany, J.P.; Ravussin, E. Metabolic and behavioral compensations in response to caloric restriction: Implications for the maintenance of weight loss. PLoS One, 2009, 4(2), e4377.
[http://dx.doi.org/10.1371/journal.pone.0004377] [PMID: 19198647]

Carlsson, A.C.; Ärnlöv, J.; Sundström, J.; Michaëlsson, K.; Byberg, L.; Lind, L. Physical activity, obesity and risk of cardiovascular disease in middle-aged men during a median of 30 years of follow-up. Eur. J. Prev. Cardiol., 2016, 23(4), 359-365.
[http://dx.doi.org/10.1177/2047487314568034] [PMID: 25604741]

Valenzuela, P.L.; Lozano, S.A.; Barrán, A.T.; Navarro, F.P.; García, C.A.; Ruilope, L.M.; Insua, R.D.; Ordovas, J.M.; Ley, V.; Lucia, A. Joint association of physical activity and body mass index with cardiovascular risk: A nationwide population-based cross-sectional study. Eur. J. Prev. Cardiol., 2022, 29(2), e50-e52.
[http://dx.doi.org/10.1093/eurjpc/zwaa151] [PMID: 33580798]

Evert, A.B.; Dennison, M.; Gardner, C.D.; Garvey, W.T.; Lau, K.H.K.; MacLeod, J.; Mitri, J.; Pereira, R.F.; Rawlings, K.; Robinson, S.; Saslow, L.; Uelmen, S.; Urbanski, P.B.; Yancy, W.S., Jr Nutrition therapy for adults with diabetes or prediabetes: A consensus report. Diabetes Care, 2019, 42(5), 731-754.
[http://dx.doi.org/10.2337/dci19-0014] [PMID: 31000505]

The Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 1999, 22(4), 623-634.
[http://dx.doi.org/10.2337/diacare.22.4.623] [PMID: 10189543]

Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: The Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol., 2015, 3(11), 866-875.
[http://dx.doi.org/10.1016/S2213-8587(15)00291-0] [PMID: 26377054]

Ceriello, A.; Esposito, K.; La Sala, L.; Pujadas, G.; De Nigris, V.; Testa, R.; Bucciarelli, L.; Rondinelli, M.; Genovese, S. The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: A preliminary report. Cardiovasc Diabetol, 2014, 13, 140.
[http://dx.doi.org/10.1186/s12933-014-0140-9]

Ismael, S.; Silvestre, M.P.; Vasques, M.; Araújo, J.R.; Morais, J.; Duarte, M.I.; Pestana, D.; Faria, A.; Pereira-Leal, J.B.; Vaz, J.; Ribeiro, P.; Teixeira, D.; Marques, C.; Calhau, C. A pilot study on the metabolic impact of mediterranean diet in type 2 diabetes: Is gut microbiota the key? Nutrients, 2021, 13(4), 1228.
[http://dx.doi.org/10.3390/nu13041228] [PMID: 33917736]

Liu, Y.; Wang, Y.; Ni, Y.; Cheung, C.K.Y.; Lam, K.S.L.; Wang, Y.; Xia, Z.; Ye, D.; Guo, J.; Tse, M.A.; Panagiotou, G.; Xu, A. Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metab., 2020, 31(1), 77-91.e5.
[http://dx.doi.org/10.1016/j.cmet.2019.11.001] [PMID: 31786155]

Baena-Díez, J.M.; Peñafiel, J.; Subirana, I.; Ramos, R.; Elosua, R.; Ibañez, M.A.; Guembe, M.J.; Rigo, F.; Díaz, T.M.J.; Iribas, M.C.; Cabré, J.J.; Segura, A.; Lareo, G.M.; de la Cámara, G.A.; Lapetra, J.; Quesada, M.; Marrugat, J.; Medrano, M.J.; Berjón, J.; Frontera, G.; Gavrila, D.; Barricarte, A.; Basora, J.; García, J.M.; Pavone, N.C.; Lora-Pablos, D.; Mayoral, E.; Franch, J.; Mata, M.; Castell, C.; Frances, A.; Grau, M. Risk of cause-specific death in individuals with diabetes: A competing risks analysis. Diabetes Care, 2016, 39(11), 1987-1995.
[http://dx.doi.org/10.2337/dc16-0614] [PMID: 27493134]

Balk, E.M.; Earley, A.; Raman, G.; Avendano, E.A.; Pittas, A.G.; Remington, P.L. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: A systematic review for the Community Preventive Services Task Force. Ann. Intern. Med., 2015, 163(6), 437-451.
[http://dx.doi.org/10.7326/M15-0452] [PMID: 26167912]

Wheeler, M.L.; Dunbar, S.A.; Jaacks, L.M.; Karmally, W.; Mayer-Davis, E.J.; Wylie-Rosett, J.; Yancy, W.S., Jr Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010. Diabetes Care, 2012, 35(2), 434-445.
[http://dx.doi.org/10.2337/dc11-2216] [PMID: 22275443]

Franz, M.J.; MacLeod, J.; Evert, A.; Brown, C.; Gradwell, E.; Handu, D.; Reppert, A.; Robinson, M. Academy of nutrition and dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: Systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J. Acad. Nutr. Diet., 2017, 117(10), 1659-1679.
[http://dx.doi.org/10.1016/j.jand.2017.03.022] [PMID: 28533169]

Gross, J.L.; Zelmanovitz, T.; Moulin, C.C.; De Mello, V.; Perassolo, M.; Leitão, C.; Hoefel, A.; Paggi, A.; Azevedo, M.J. Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: A randomized crossover trial. Diabetes Care, 2002, 25(4), 645-651.
[http://dx.doi.org/10.2337/diacare.25.4.645] [PMID: 11919119]

Trumbo, P.; Schlicker, S.; Yates, A.A.; Poos, M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J. Am. Diet. Assoc., 2002, 102(11), 1621-1630.
[http://dx.doi.org/10.1016/S0002-8223(02)90346-9] [PMID: 12449285]

Salas-Salvadó, J.; Bulló, M.; Estruch, R.; Ros, E.; Covas, M.I.; Jurado, I.N.; Corella, D.; Arós, F.; Gracia, G.E.; Gutiérrez, R.V.; Romaguera, D.; Lapetra, J.; Raventós, L.R.M.; Majem, S.L.; Pintó, X.; Basora, J.; Muñoz, M.A.; Sorlí, J.V.; González, M.M.A. Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial. Ann. Intern. Med., 2014, 160(1), 1-10.
[http://dx.doi.org/10.7326/M13-1725] [PMID: 24573661]

Esposito, K.; Chiodini, P.; Maiorino, M.I.; Bellastella, G.; Panagiotakos, D.; Giugliano, D. Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine, 2014, 47(1), 107-116.
[http://dx.doi.org/10.1007/s12020-014-0264-4] [PMID: 24744219]

Chiu, T.H.T.; Pan, W.H.; Lin, M.N.; Lin, C.L. Vegetarian diet, change in dietary patterns, and diabetes risk: A prospective study. Nutr. Diabetes, 2018, 8(1), 12.
[http://dx.doi.org/10.1038/s41387-018-0022-4] [PMID: 29549240]

Kahleova, H.; Pelikanova, T. Vegetarian diets in the prevention and treatment of type 2 diabetes. J. Am. Coll. Nutr., 2015, 34(5), 448-458.
[http://dx.doi.org/10.1080/07315724.2014.976890] [PMID: 25915002]

Schwingshackl, L.; Bogensberger, B.; Hoffmann, G. Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: An updated systematic review and meta-analysis of cohort studies. J. Acad. Nutr. Diet., 2018, 118(1), 74-100.e11.
[http://dx.doi.org/10.1016/j.jand.2017.08.024] [PMID: 29111090]

Cauter, V.E.; Knutson, K.L. Sleep and the epidemic of obesity in children and adults. Eur. J. Endocrinol., 2008, 159(S1), S59-S66.
[http://dx.doi.org/10.1530/EJE-08-0298] [PMID: 18719052]

Van Cauter, E.; Spiegel, K.; Tasali, E.; Leproult, R. Metabolic consequences of sleep and sleep loss. Sleep Med., 2008, 9(1), S23-S28.
[http://dx.doi.org/10.1016/S1389-9457(08)70013-3]

Antza, C.; Kostopoulos, G.; Mostafa, S.; Nirantharakumar, K.; Tahrani, A. The links between sleep duration, obesity and type 2 diabetes mellitus. J. Endocrinol., 2022, 252(2), 125-141.
[http://dx.doi.org/10.1530/JOE-21-0155] [PMID: 34779405]

Iyegha, I.D.; Chieh, A.Y.; Bryant, B.M.; Li, L. Associations between poor sleep and glucose intolerance in prediabetes. Psychoneuroendocrinology, 2019, 110, 104444.
[http://dx.doi.org/10.1016/j.psyneuen.2019.104444] [PMID: 31546116]

Rafalson, L.; Donahue, R.P.; Stranges, S.; Lamonte, M.J.; Dmochowski, J.; Dorn, J.; Trevisan, M. Short sleep duration is associated with the development of impaired fasting glucose: The Western New York Health Study. Ann. Epidemiol., 2010, 20(12), 883-889.
[http://dx.doi.org/10.1016/j.annepidem.2010.05.002] [PMID: 20620078]

Mostafa, S.A.; Mena, S.C.; Antza, C.; Balanos, G.; Nirantharakumar, K.; Tahrani, A.A. Sleep behaviours and associated habits and the progression of pre-diabetes to type 2 diabetes mellitus in adults: A systematic review and meta-analysis. Diab. Vasc. Dis. Res., 2022, 19(3), 1-11.
[http://dx.doi.org/10.1177/14791641221088824] [PMID: 35616501]

Pan, X.R.; Li, G.W.; Hu, Y.H.; Wang, J.X.; Yang, W.Y.; An, Z.X.; Hu, Z.X.; Juan-Lin; Xiao, J.Z.; Cao, H.B.; Liu, P.A.; Jiang, X.G.; Jiang, Y.Y.; Wang, J.P.; Zheng, H.; Zhang, H.; Bennett, P.H.; Howard, B.V. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 1997, 20(4), 537-544.
[http://dx.doi.org/10.2337/diacare.20.4.537] [PMID: 9096977]

Knowler, W.C.; Fowler, S.E.; Hamman, R.F.; Christophi, C.A.; Hoffman, H.J.; Brenneman, A.T.; Brown-Friday, J.O.; Goldberg, R.; Venditti, E.; Nathan, D.M. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet, 2009, 374(9702), 1677-1686.
[http://dx.doi.org/10.1016/S0140-6736(09)61457-4] [PMID: 19878986]

Lindström, J.; Ilanne-Parikka, P.; Peltonen, M.; Aunola, S.; Eriksson, J.G.; Hemiö, K.; Hämäläinen, H.; Härkönen, P.; Kiukaanniemi, K.S.; Laakso, M.; Louheranta, A.; Mannelin, M.; Paturi, M.; Sundvall, J.; Valle, T.T.; Uusitupa, M.; Tuomilehto, J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the finnish diabetes prevention study. Lancet, 2006, 368(9548), 1673-1679.
[http://dx.doi.org/10.1016/S0140-6736(06)69701-8] [PMID: 17098085]

Hamman, R.F.; Wing, R.R.; Edelstein, S.L.; Lachin, J.M.; Bray, G.A.; Delahanty, L.; Hoskin, M.; Kriska, A.M.; Mayer-Davis, E.J.; Pi-Sunyer, X.; Regensteiner, J.; Venditti, B.; Rosett, W.J. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care, 2006, 29(9), 2102-2107.
[http://dx.doi.org/10.2337/dc06-0560] [PMID: 16936160]

Castellana, M.; Conte, E.; Cignarelli, A.; Perrini, S.; Giustina, A.; Giovanella, L.; Giorgino, F.; Trimboli, P. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis. Rev. Endocr. Metab. Disord., 2020, 21(1), 5-16.
[http://dx.doi.org/10.1007/s11154-019-09514-y] [PMID: 31705259]

Bueno, N.B.; de Melo, I.S.V.; de Oliveira, S.L.; da Rocha Ataide, T. Very-low-carbohydrate ketogenic diet vs. low-fat diet for long-term weight loss: A meta-analysis of randomised controlled trials. Br. J. Nutr., 2013, 110(7), 1178-1187.
[http://dx.doi.org/10.1017/S0007114513000548] [PMID: 23651522]

Casanueva, F.F.; Castellana, M.; Bellido, D.; Trimboli, P.; Castro, A.I.; Sajoux, I.; Carnero, R.G.; Arbelaez, G.D.; Crujeiras, A.B.; Olmos, M.M.A. Ketogenic diets as treatment of obesity and type 2 diabetes mellitus. Rev. Endocr. Metab. Disord., 2020, 21(3), 381-397.
[http://dx.doi.org/10.1007/s11154-020-09580-7] [PMID: 32803691]

Moreno, B.; Crujeiras, A.B.; Bellido, D.; Sajoux, I.; Casanueva, F.F. Obesity treatment by very low-calorie-ketogenic diet at two years: Reduction in visceral fat and on the burden of disease. Endocrine, 2016, 54(3), 681-690.
[http://dx.doi.org/10.1007/s12020-016-1050-2] [PMID: 27623967]

Caprio, M.; Infante, M.; Moriconi, E.; Armani, A.; Fabbri, A.; Mantovani, G.; Mariani, S.; Lubrano, C.; Poggiogalle, E.; Migliaccio, S.; Donini, L.M.; Basciani, S.; Cignarelli, A.; Conte, E.; Ceccarini, G.; Bogazzi, F.; Cimino, L.; Condorelli, R.A.; La Vignera, S.; Calogero, A.E.; Gambineri, A.; Vignozzi, L.; Prodam, F.; Aimaretti, G.; Linsalata, G.; Buralli, S.; Monzani, F.; Aversa, A.; Vettor, R.; Santini, F.; Vitti, P.; Gnessi, L.; Pagotto, U.; Giorgino, F.; Colao, A.; Lenzi, A.; Caprio, M.; Bogazzi, F.; Beccuti, G.; Biondi, B.; Cannavò, S.; Chiodini, I.; De Feudis, G.; Di Francesco, S.; Di Gregorio, A.; Fallo, F.; Foresta, C.; Giacchetti, G.; Granata, R.; Isidori, A.M.; Magni, P.; Maiellaro, P.; Caprino, M.P.; Pivonello, R.; Pofi, R.; Pontecorvi, A.; Simeoli, C. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: Systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J. Endocrinol. Invest., 2019, 42(11), 1365-1386.
[http://dx.doi.org/10.1007/s40618-019-01061-2] [PMID: 31111407]

Gomez-Arbelaez, D.; Bellido, D.; Castro, A.I.; Ordoñez-Mayan, L.; Carreira, J.; Galban, C.; Martinez-Olmos, M.A.; Crujeiras, A.B.; Sajoux, I.; Casanueva, F.F. Body composition changes after very-low-calorie ketogenic diet in obesity evaluated by 3 standardized methods. J. Clin. Endocrinol. Metab., 2017, 102(2), 488-498.
[http://dx.doi.org/10.1210/jc.2016-2385] [PMID: 27754807]

Kaul, S.; Rothney, M.P.; Peters, D.M.; Wacker, W.K.; Davis, C.E.; Shapiro, M.D.; Ergun, D.L. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity, 2012, 20(6), 1313-1318.
[http://dx.doi.org/10.1038/oby.2011.393] [PMID: 22282048]

Micklesfield, L.K.; Goedecke, J.H.; Punyanitya, M.; Wilson, K.E.; Kelly, T.L. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity, 2012, 20(5), 1109-1114.
[http://dx.doi.org/10.1038/oby.2011.367] [PMID: 22240726]

Gu, Y.; Yu, H.; Li, Y.; Ma, X.; Lu, J.; Yu, W.; Xiao, Y.; Bao, Y.; Jia, W. Beneficial effects of an 8-week, very low carbohydrate diet intervention on obese subjects. Evid. Based Complement. Alternat. Med., 2013, 2013, 1-8.
[http://dx.doi.org/10.1155/2013/760804] [PMID: 23573151]

Svendsen, P.F.; Jensen, F.K.; Holst, J.J.; Haugaard, S.B.; Nilas, L.; Madsbad, S. The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women. Scand. J. Clin. Lab. Invest., 2012, 72(5), 410-419.
[http://dx.doi.org/10.3109/00365513.2012.691542] [PMID: 22708619]

Demol, S.; Yackobovitch-Gavan, M.; Shalitin, S.; Nagelberg, N.; Gillon-Keren, M.; Phillip, M. Low‐carbohydrate (low & high‐fat) versus high‐carbohydrate low‐fat diets in the treatment of obesity in adolescents. Acta Paediatr., 2009, 98(2), 346-351.
[http://dx.doi.org/10.1111/j.1651-2227.2008.01051.x] [PMID: 18826492]

Partsalaki, I.; Karvela, A.; Spiliotis, B.E. Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents. J. Pediatr. Endocrinol. Metab., 2012, 25(7-8), 697-704.
[http://dx.doi.org/10.1515/jpem-2012-0131] [PMID: 23155696]

Goday, A.; Bellido, D.; Sajoux, I.; Crujeiras, A.B.; Burguera, B.; García-Luna, P.P.; Oleaga, A.; Moreno, B.; Casanueva, F.F. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr. Diabetes, 2016, 6(9), e230.
[http://dx.doi.org/10.1038/nutd.2016.36] [PMID: 27643725]

Saslow, L.R.; Daubenmier, J.J.; Moskowitz, J.T.; Kim, S.; Murphy, E.J.; Phinney, S.D.; Ploutz-Snyder, R.; Goldman, V.; Cox, R.M.; Mason, A.E.; Moran, P.; Hecht, F.M. Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr. Diabetes, 2017, 7(12), 304.
[http://dx.doi.org/10.1038/s41387-017-0006-9] [PMID: 29269731]

La Vignera, S.; Cannarella, R.; Galvano, F.; Grillo, A.; Aversa, A.; Cimino, L.; Magagnini, C.M.; Mongioì, L.M.; Condorelli, R.A.; Calogero, A.E. The ketogenic diet corrects metabolic hypogonadism and preserves pancreatic ß-cell function in overweight/obese men: A single-arm uncontrolled study. Endocrine, 2021, 72(2), 392-399.
[http://dx.doi.org/10.1007/s12020-020-02518-8] [PMID: 33063272]

Engin, A. The definition and prevalence of obesity and metabolic syndrome. Adv. Exp. Med. Biol., 2017, 960, 1-17.
[http://dx.doi.org/10.1007/978-3-319-48382-5_1] [PMID: 28585193]

Nijpels, G.; Popp-Snijders, C.; Kostense, P.J.; Bouter, L.M.; Heine, R.J. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: The Hoorn Study. Diabetologia, 1996, 39(1), 113-118.
[http://dx.doi.org/10.1007/BF00400421] [PMID: 8720611]

Pfützner, A.; Pfützner, A.H.; Larbig, M.; Forst, T. Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus. Diabetes Technol. Ther., 2004, 6(3), 405-412.
[http://dx.doi.org/10.1089/152091504774198124] [PMID: 15198846]

Pfützner, A.; Kann, P.H.; Pfützner, A.H.; Kunt, T.; Larbig, M.; Weber, M.M.; Forst, T. Intact and total proinsulin: New aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance. Clin. Lab., 2004, 50(9-10), 567-573.
[PMID: 15481632]

Zethelius, B.; Byberg, L.; Hales, C.N.; Lithell, H.; Berne, C. Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men—report from 27 years of follow-up study. Diabetologia, 2003, 46(1), 20-26.
[http://dx.doi.org/10.1007/s00125-002-0995-2] [PMID: 12637978]

Bolinder, J.; Fernlund, P.; Borg, H.; Arnqvist, H.J.; Björk, E.; Blohmé, G.; Eriksson, J.W.; Nyström, L.; Östman, J.; Sundkvist, G. Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes. Scand. J. Clin. Lab. Invest., 2005, 65(7), 585-594.
[http://dx.doi.org/10.1080/00365510500261869] [PMID: 16271990]

Vangipurapu, J.; Stančáková, A.; Kuulasmaa, T.; Kuusisto, J.; Laakso, M. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: A population-based study of 9,396 Finnish men. PLoS One, 2015, 10(4), e0124028.
[http://dx.doi.org/10.1371/journal.pone.0124028] [PMID: 25853252]

Ohkura, T.; Inoue, K.; Fujioka, Y.; Nakanishi, R.; Shiochi, H.; Sumi, K.; Yamamoto, N.; Matsuzawa, K.; Izawa, S.; Ohkura, H.; Kato, M.; Yamamoto, K.; Taniguchi, S. The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: A small-scale clinical study. BMC Res. Notes, 2013, 6(1), 453.
[http://dx.doi.org/10.1186/1756-0500-6-453] [PMID: 24215809]

Choi, Y.J.; Jeon, S.M.; Shin, S. Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: A meta-analysis of randomized controlled trials. Nutrients, 2020, 12(7), 2005.
[http://dx.doi.org/10.3390/nu12072005] [PMID: 32640608]

Kumar, S.; Behl, T.; Sachdeva, M.; Sehgal, A.; Kumari, S.; Kumar, A.; Kaur, G.; Yadav, H.N.; Bungau, S. Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus. Life Sci., 2021, 264, 118661.
[http://dx.doi.org/10.1016/j.lfs.2020.118661] [PMID: 33121986]

Fatati, G. VLCD E VLCKD nel trattamento di obesi affetti da diabete non insulinodipendente o prediabete: Evidenze e riflessioni cliniche. Rec. Prog. Med., 2020, 111(9), 492-502.
[PMID: 32914777]

Torgerson, J.S.; Hauptman, J.; Boldrin, M.N.; Sjöström, L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004, 27(1), 155-161.
[http://dx.doi.org/10.2337/diacare.27.1.155] [PMID: 14693982]

le Roux, C.W.; Astrup, A.; Fujioka, K.; Greenway, F.; Lau, D.C.W.; Van Gaal, L.; Ortiz, R.V.; Wilding, J.P.H.; Skjøth, T.V.; Manning, L.S.; Pi-Sunyer, X.; Hamann, A.; Barakat, A.; Blüher, M.; Linn, T.; Mölle, A.; Segner, A.; Stübler, P.; Tosch-Sisting, R.; Pacini, F.; Santini, F.; Marchesini, G.; Rotella, C.M.; Invitti, C.; Vettor, R.; Buscemi, S.; Raya, P.M.; Freijoo, F.C.; de Barbará, R.G.; Carraro, R.; Bobillo, E.R.; de la Cuesta, C.; Farsang, C.; Csaszar, A.; Markiewicz, Z.B.; Musialik, P.D.; Franek, E.; Ostrowska, L.; Glinianowicz, O.M.; Lalic, N.; Micic, D.; Ludvik, B.; Paulweber, B.; Prager, R.; Scheen, A.; Van Gaal, L.; Astrup, A.V.; Hermansen, K.; Madsbad, S.; Rissanen, A.; Nieminen, S.; Savolainen, M.; Krempf, M.; Romon, M.; Laville, M.; Marre, M.; Mira, R.; Finucane, F.; Veenendaal, A.; van Berkum, F.; Vidarsdóttir, J.S.; Van de Walle, V.; Meesters, E.; Hjelmesæth, J.; Klemsdal, T.O.; Kulseng, B.; Bach-Kliegel, B.; Laederach, K.; Villiger, L.; Golay, A.; Bilz, S.; Sathyapalan, T.; Bain, S.; Kumar, S.; Le Roux, C.W.; Lean, M.E.J.; McGowan, B.; Rehman, T.; Wilding, J.; Wittert, G.; Caterson, I.; Proietto, J.; Prins, J.; Neto, B.G.; Gross, J.L.; Chacra, A.R.; Halpern, A.; de Suplicy, A.H.; Chow, F.C.C.; Thacker, H.P.; Chadha, M.; Chandalia, H.; Unnikrishnan, A.; Kalra, S.; Deshpande, N.; Shunmugavelu, M.; Deshmukh, V.C.; Maislos, M.; Lieberman, G.S.; Shimon, I.; Stern, N.; Nabriski, D.; Karnieli, E.; Shehadeh, N.; Galvez, G.G.; del Granell, R.A.M.; Ortiz, R.M.V.; Franco, G.M.; Gurieva, I.; Suplotova, L.A.; Troshina, E.; Ruyatkina, L.A.; Voychik, E.A.; Martsevich, S.; Startseva, M.A.; Seeber, M.E.; Badat, A.; Ellis, G.; Altuntas, Y.; Guler, S.; Ulgen, E.; Delibasi, T.; Chetty, T.; Hart, R.; Janzen, J.; Labonte, I.; Lau, D.; Liutkus, J.; O’Keefe, D.; Padwal, R.; Ransom, T.P.P.; Tytus, R.; Weisnagel, S.J.; Adler, J.; Aqua, K.; Aronoff, S.L.; Bedel, G.W.; Blevins, T.C.; Blumenau, J.; Brockmyre, A.P.; Call, R.S.; Canadas, R.; Chaykin, L.B.; Cohen, K.; Conrow, J.K.; Davis, M.G.; Downey, H.J.; Drosman, S.R.; Duckor, S.; Farmer, H.F.; Farrell, J.; Fehnel, S.; Finneran, M.P.; Forbes, R.; Forker, A.; Fredrick, M.; Fujioka, K.; Geller, S.A.; Gill, S.; Glaser, L.; Greco, S.N.; Greenway, F.L.; Harper, W.; Herman, L.; Hoekstra, J.; Ingebretsen, R.; Ison, R.; Jain, R.K.; Kaplan, R.; Kaster, S.R.; Haase, G.A.; Kerzner, B.; Kirstein, J.L.; Koltun, W.; Krieger, D.R.; Lewis, C.E.; Madder, R.; Marple, R.N.; McDermott, E.J.; Mello, C.J.; Miller, A.B.; Mullen, J.; Nardandrea, J.; O’Neil, P.; Pi-Sunyer, F.X.; Pucillo, R.M.; Rhee, C.; Redrick, S.; Pardini, A.; Rothman, J.; Rubino, D.M.; Sellers, G.; Smith, T.; Byars, W.D.; Soufer, J.; Sussman, A.M.; Patrick, K.; Schramm, E.L.; Van Cleeff, M.; Berg, S.R.; Wyatt, H.R.; Simon, J.A. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: A randomised, double-blind trial. Lancet, 2017, 389(10077), 1399-1409.
[http://dx.doi.org/10.1016/S0140-6736(17)30069-7] [PMID: 28237263]

Wilding, J.P.H.; Batterham, R.L.; Calanna, S.; Davies, M.; Van Gaal, L.F.; Lingvay, I.; McGowan, B.M.; Rosenstock, J.; Tran, M.T.D.; Wadden, T.A.; Wharton, S.; Yokote, K.; Zeuthen, N.; Kushner, R.F. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med., 2021, 384(11), 989-1002.
[http://dx.doi.org/10.1056/NEJMoa2032183] [PMID: 33567185]

Hankosky, E.R.; Wang, H.; Neff, L.M.; Kan, H.; Wang, F.; Ahmad, N.N.; Stefanski, A.; Garvey, W.T. Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT ‐1 trial. Diabetes Obes. Metab., 2023, 25(12), 3748-3756.
[http://dx.doi.org/10.1111/dom.15269] [PMID: 37700443]

Sjöström, L. Review of the key results from the Swedish Obese Subjects ( SOS ) trial – A prospective controlled intervention study of bariatric surgery. J. Intern. Med., 2013, 273(3), 219-234.
[http://dx.doi.org/10.1111/joim.12012] [PMID: 23163728]

Johnson, A.B.; Webster, J.M.; Sum, C.F.; Heseltine, L.; Argyraki, M.; Cooper, B.G.; Taylor, R. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism, 1993, 42(9), 1217-1222.
[http://dx.doi.org/10.1016/0026-0495(93)90284-U] [PMID: 8412779]

Wright, A.D.; Cull, C.A.; Macleod, K.M.; Holman, R.R. Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. J. Diabetes Complications, 2006, 20(6), 395-401.
[http://dx.doi.org/10.1016/j.jdiacomp.2005.08.010] [PMID: 17070446]

Madsen, K.S.; Chi, Y.; Metzendorf, M.I.; Richter, B.; Hemmingsen, B. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Libr., 2019, 2019(12), CD008558.
[http://dx.doi.org/10.1002/14651858.CD008558.pub2] [PMID: 31794067]

Herman, W.H.; Hoerger, T.J.; Brandle, M.; Hicks, K.; Sorensen, S.; Zhang, P.; Hamman, R.F.; Ackermann, R.T.; Engelgau, M.M.; Ratner, R.E. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann. Intern. Med., 2005, 142(5), 323-332.
[http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00007] [PMID: 15738451]

Zinman, B.; Harris, S.B.; Neuman, J.; Gerstein, H.C.; Retnakaran, R.R.; Raboud, J.; Qi, Y.; Hanley, A.J.G. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study. Lancet, 2010, 376(9735), 103-111.
[http://dx.doi.org/10.1016/S0140-6736(10)60746-5] [PMID: 20605202]

Rosenstock, J.; Klaff, L.J.; Schwartz, S.; Northrup, J.; Holcombe, J.H.; Wilhelm, K.; Trautmann, M. Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. Diabetes Care, 2010, 33(6), 1173-1175.
[http://dx.doi.org/10.2337/dc09-1203] [PMID: 20332357]

Frías, J.P.; Davies, M.J.; Rosenstock, J.; Manghi, P.F.C.; Landó, L.; Bergman, B.K.; Liu, B.; Cui, X.; Brown, K. SURPASS-2 Investigators. Tirzepatide versus Semaglutide once weekly in patients with type 2 diabetes. N. Engl. J. Med., 2021, 385(6), 503-515.
[http://dx.doi.org/10.1056/NEJMoa2107519] [PMID: 34170647]

Monami, M.; Nardini, C.; Mannucci, E. Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: A meta‐analysis of randomized clinical trials. Diabetes Obes. Metab., 2014, 16(5), 457-466.
[http://dx.doi.org/10.1111/dom.12244] [PMID: 24320621]

Lundkvist, P.; Pereira, M.J.; Katsogiannos, P.; Sjöström, C.D.; Johnsson, E.; Eriksson, J.W. Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Diabetes Obes. Metab., 2017, 19(9), 1276-1288.
[http://dx.doi.org/10.1111/dom.12954] [PMID: 28345814]

McMurray, J.J.V.; Solomon, S.D.; Inzucchi, S.E.; Køber, L.; Kosiborod, M.N.; Martinez, F.A.; Ponikowski, P.; Sabatine, M.S.; Anand, I.S.; Bělohlávek, J.; Böhm, M.; Chiang, C.E.; Chopra, V.K.; de Boer, R.A.; Desai, A.S.; Diez, M.; Drozdz, J.; Dukát, A.; Ge, J.; Howlett, J.G.; Katova, T.; Kitakaze, M.; Ljungman, C.E.A.; Merkely, B.; Nicolau, J.C.; O’Meara, E.; Petrie, M.C.; Vinh, P.N.; Schou, M.; Tereshchenko, S.; Verma, S.; Held, C.; DeMets, D.L.; Docherty, K.F.; Jhund, P.S.; Bengtsson, O.; Sjöstrand, M.; Langkilde, A.M. Dapagliflozin in patients with heart failure and reduced ejection fraction. N. Engl. J. Med., 2019, 381(21), 1995-2008.
[http://dx.doi.org/10.1056/NEJMoa1911303] [PMID: 31535829]

Inzucchi, S.E.; Docherty, K.F.; Køber, L.; Kosiborod, M.N.; Martinez, F.A.; Ponikowski, P.; Sabatine, M.S.; Solomon, S.D.; Verma, S.; Bělohlávek, J.; Böhm, M.; Chiang, C.E.; de Boer, R.A.; Diez, M.; Dukát, A.; Ljungman, C.E.A.; Bengtsson, O.; Langkilde, A.M.; Sjöstrand, M.; Jhund, P.S.; McMurray, J.J.V. Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: An exploratory analysis from DAPA-HF. Diabetes Care, 2021, 44(2), 586-594.
[http://dx.doi.org/10.2337/dc20-1675] [PMID: 33355302]

Anker, S.D.; Butler, J.; Filippatos, G.; Ferreira, J.P.; Bocchi, E.; Böhm, M.; Rocca, B.L.H.P.; Choi, D.J.; Chopra, V.; Valenzuela, C.E.; Giannetti, N.; Mesa, G.J.E.; Janssens, S.; Januzzi, J.L.; Juanatey, G.J.R.; Merkely, B.; Nicholls, S.J.; Perrone, S.V.; Piña, I.L.; Ponikowski, P.; Senni, M.; Sim, D.; Spinar, J.; Squire, I.; Taddei, S.; Tsutsui, H.; Verma, S.; Vinereanu, D.; Zhang, J.; Carson, P.; Lam, C.S.P.; Marx, N.; Zeller, C.; Sattar, N.; Jamal, W.; Schnaidt, S.; Schnee, J.M.; Brueckmann, M.; Pocock, S.J.; Zannad, F.; Packer, M. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med., 2021, 385(16), 1451-1461.
[http://dx.doi.org/10.1056/NEJMoa2107038] [PMID: 34449189]

Rossing, P.; Inzucchi, S.E.; Vart, P.; Jongs, N.; Docherty, K.F.; Jhund, P.S.; Køber, L.; Kosiborod, M.N.; Martinez, F.A.; Ponikowski, P.; Sabatine, M.S.; Solomon, S.D.; DeMets, D.L.; Bengtsson, O.; Lindberg, M.; Langkilde, A.M.; Sjöstrand, M.; Stefansson, B.V.; Karlsson, C.; Chertow, G.M.; Hou, F.F.; Correa-Rotter, R.; Toto, R.D.; Wheeler, D.C.; McMurray, J.J.V.; Heerspink, H.J.L. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: Pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes Endocrinol., 2022, 10(1), 24-34.
[http://dx.doi.org/10.1016/S2213-8587(21)00295-3] [PMID: 34856173]

Heerspink, H.J.L.; Stefánsson, B.V.; Correa-Rotter, R.; Chertow, G.M.; Greene, T.; Hou, F.F.; Mann, J.F.E.; McMurray, J.J.V.; Lindberg, M.; Rossing, P.; Sjöström, C.D.; Toto, R.D.; Langkilde, A.M.; Wheeler, D.C. Dapagliflozin in patients with chronic kidney disease. N. Engl. J. Med., 2020, 383(15), 1436-1446.
[http://dx.doi.org/10.1056/NEJMoa2024816] [PMID: 32970396]

Chilcott, J.; Tappenden, P.; Jones, M.L.; Wight, J.P. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. Clin. Ther., 2001, 23(11), 1792-1823.
[http://dx.doi.org/10.1016/S0149-2918(00)80078-8] [PMID: 11768834]

DeFronzo, R.A.; Banerji, M.; Bray, G.A.; Buchanan, T.A.; Clement, S.; Henry, R.R.; Kitabchi, A.E.; Mudaliar, S.; Musi, N.; Ratner, R.; Reaven, P.D.; Schwenke, D.; Stentz, F.B.; Tripathy, D. Actos Now for the prevention of diabetes (ACT NOW) study. BMC Endocr. Disord., 2009, 9(1), 17.
[http://dx.doi.org/10.1186/1472-6823-9-17] [PMID: 19640291]

DeFronzo, R.A.; Tripathy, D.; Schwenke, D.C.; Banerji, M.; Bray, G.A.; Buchanan, T.A.; Clement, S.C.; Gastaldelli, A.; Henry, R.R.; Kitabchi, A.E.; Mudaliar, S.; Ratner, R.E.; Stentz, F.B.; Musi, N.; Reaven, P.D. Prevention of diabetes with pioglitazone in ACT NOW: Physiologic correlates. Diabetes, 2013, 62(11), 3920-3926.
[http://dx.doi.org/10.2337/db13-0265] [PMID: 23863810]

Tripathy, D.; Schwenke, D.C.; Banerji, M.; Bray, G.A.; Buchanan, T.A.; Clement, S.C.; Henry, R.R.; Kitabchi, A.E.; Mudaliar, S.; Ratner, R.E.; Stentz, F.B.; Musi, N.; Reaven, P.D.; DeFronzo, R.A. Diabetes incidence and glucose tolerance after termination of pioglitazone therapy: Results from ACT NOW. J. Clin. Endocrinol. Metab., 2016, 101(5), 2056-2062.
[http://dx.doi.org/10.1210/jc.2015-4202] [PMID: 26982008]

Chiasson, J.L.; Josse, R.G.; Gomis, R.; Hanefeld, M.; Karasik, A.; Laakso, M. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet, 2002, 359(9323), 2072-2077.
[http://dx.doi.org/10.1016/S0140-6736(02)08905-5] [PMID: 12086760]

Holman, R.R.; Coleman, R.L.; Chan, J.C.N.; Chiasson, J.L.; Feng, H.; Ge, J.; Gerstein, H.C.; Gray, R.; Huo, Y.; Lang, Z.; McMurray, J.J.; Rydén, L.; Schröder, S.; Sun, Y.; Theodorakis, M.J.; Tendera, M.; Tucker, L.; Tuomilehto, J.; Wei, Y.; Yang, W.; Wang, D.; Hu, D.; Pan, C.; Keenan, J.; Milton, J.; Doran, Z.; Bray, C.; Rouleau, J.L.; Collier, J.; Pocock, S.; Standl, E.; Swedberg, K.; Weng, J.; Zhao, D.; Petrie, M.C.; Connolly, E.; Jhund, P.; MacDonald, M.; Myles, R.C.; Bai, R.; Li, J.; Liu, Z.; Liu, Z.; Peng, D.; Tong, Q.; Wang, C.; Yan, X.; Zhang, Y.; Zhou, J.; Sattar, N.; Fisher, M.; Petrie, J.R.; Bethel, M.A.; Xu, W.; Hearn, S.; Kappai, A.; Su, S-Y.; Liyanage, W.; Paul, S.; Pozzi, E.; Ring, A.; Athwal, R.; Batra, P.; Ferch, A.; Groves, N.; Kennedy, I.; Nawalaniec, O.; Patel, Y.; Roberts, R.; Rush, V.; Starrett, J.; Tang, J.; Bi, J.; Jiang, Z.; Wei, H.; Wei, X.; Zhang, X.; Yin, J.; Sun, Y.; Hu, R.; Liu, Y.; Long, J.; Long, Y.; Qiao, G.; Qiao, H.; Sun, X.; Zhang, Y.; Zhou, J.; Wang, B.; Chen, B.; Deng, L.; Han, X.; Hu, T.; Hua, Q.; Huo, Y.; Li, H.; Li, H.; Liu, L.; Lu, J.; Ma, C.; Peng, J.; Pi, L.; Wang, B.; Wei, G.; Yang, M.; Zhang, S.; Zhang, L.; Zhao, X.; Zhou, Y.; Shi, L.; Wang, M.; Wu, L.; Han, L.; Liao, R.; Ran, B.; She, Q.; Tan, J.; Xia, M.; Yang, C.; Chen, L.; Xiong, S.; Yu, L.; Pu, X.; Wang, Y.; Xie, Q.; Chen, C.; Chen, J.; Dong, Y.; Wu, Z.; Yuan, Y.; Zhou, W.; Zhou, S.; Chen, X.; Wu, C.; Zhang, A.; Li, Z.; Lai, S.; Yang, J.; Wei, J.; Kuang, R.; Zhao, Z.; Zhong, G.; Cao, X.; Hao, Y.; Liu, G.; Wang, D.; Fang, H.; Kong, L.; Li, H.; Wang, C.; Wang, L.; Li, X.; Dong, P.; Zhang, S.; Liu, X.; Zhao, Y.; Liu, H.; Gu, Y.; Liao, Y.; Su, X.; Wang, D.; Wang, H.; Yang, B.; Guo, Y.; Ouyang, D.; Yang, T.; Zhang, Y.; Han, Y.; Lin, X.; Zhao, R.; Man, R.; Bian, R.; Biao, X.; Hasimu, B.; Jin, H.; Liu, P.; Yu, J.; Zhang, H.; Xu, C.; Guo, Y.; Lv, K.; Tao, Y.; Xu, X.; Yang, Z.; Li, D.; Qi, C.; Zhang, G.; Gu, X.; Hong, L.; Hu, L.; Li, J.; Yang, P.; Liu, B.; Wang, G.; Lin, H.; Liu, J.; Zhang, S.; Han, P.; Jin, Y.; Li, L.; Li, Z.; Luan, H.; Song, M.; Xue, L.; Hua, Y.; Liu, D.; Yuan, Z.; Ye, J.; Gao, F.; Feng, J.; Wang, A.; Ye, S.; Li, X.; Su, G.; Zhang, S.; Hou, Z.; Jiang, W.; Zhou, C.; Wang, Y.; Qi, W.; Bao, X.; Feng, B.; Gong, H.; Gu, S.; Gu, M.; Guo, X.; He, B.; Huang, Y.; Jiang, J.; Jiang, Y.; Jin, H.; Li, Y.; Liu, Q.; Lu, G.; Miao, P.; Qin, Y.; Wang, B.; Wang, Y.; Wu, S.; Xu, Y.; Ma, J.; Chen, X.; Liu, X.; Tang, J.; Wang, J.; Chen, X.; Tao, J.; Zhang, J.; Zhang, T.; Li, D.; Du, X.; Jiang, T.; Lin, J.; Lu, C.; Ma, H.; Gao, B.; Guo, X.; Li, T.; Zheng, S.; Li, Z.; Zhao, S.; Qiu, Q.; Li, K.; Liu, J.; Tang, B.; Yuan, Z.; Zhou, J.; Bai, W.; Guo, T.; Zhang, G.; Zhang, H.; Hao, Y.; Fu, G.; Tang, L.; Chen, J. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): A randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol., 2017, 5(11), 877-886.
[http://dx.doi.org/10.1016/S2213-8587(17)30309-1] [PMID: 28917545]

Coleman, R.L.; Scott, C.A.B.; Lang, Z.; Bethel, M.A.; Tuomilehto, J.; Holman, R.R. Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes. Cardiovasc. Diabetol., 2019, 18(1), 135.
[http://dx.doi.org/10.1186/s12933-019-0933-y] [PMID: 31623625]

Garber, A.J.; Handelsman, Y.; Grunberger, G.; Einhorn, D.; Abrahamson, M.J.; Barzilay, J.I.; Blonde, L.; Bush, M.A.; DeFronzo, R.A.; Garber, J.R.; Garvey, W.T.; Hirsch, I.B.; Jellinger, P.S.; McGill, J.B.; Mechanick, J.I.; Perreault, L.; Rosenblit, P.D.; Samson, S.; Umpierrez, G.E. Consensus statement by the American Association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm -2020 executive summary. Endocr. Pract., 2020, 26(1), 107-139.
[http://dx.doi.org/10.4158/CS-2019-0472] [PMID: 32022600]

Catena, C.; Colussi, G.; Martinis, F.; Pezzutto, F.; Sechi, L.A. Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients. Am. J. Hypertens., 2013, 26(11), 1353-1361.
[http://dx.doi.org/10.1093/ajh/hpt114] [PMID: 23846724]

Emdin, C.A.; Anderson, S.G.; Woodward, M.; Rahimi, K. Usual blood pressure and risk of new-onset diabetes: Evidence from 4.1 million adults and a meta-analysis of prospective studies. J. Am. Coll. Cardiol., 2015, 66(14), 1552-1562.
[http://dx.doi.org/10.1016/j.jacc.2015.07.059] [PMID: 26429079]

Qiu, M.; Shen, W.; Song, X.; Ju, L.; Tong, W.; Wang, H.; Zheng, S.; Jin, Y.; Wu, Y.; Wang, W.; Tian, J. Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: Longitudinal study. Hypertension, 2015, 65(3), 525-530.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04632] [PMID: 25624343]

Bangalore, S.; Kumar, S.; Lobach, I.; Messerli, F.H. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: Observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation, 2011, 123(24), 2799-2810, 9, 810.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.110.016337] [PMID: 21632497]

Cosentino, F.; Grant, P.J.; Aboyans, V.; Bailey, C.J.; Ceriello, A.; Delgado, V.; Federici, M.; Filippatos, G.; Grobbee, D.E.; Hansen, T.B.; Huikuri, H.V.; Johansson, I.; Jüni, P.; Lettino, M.; Marx, N.; Mellbin, L.G.; Östgren, C.J.; Rocca, B.; Roffi, M.; Sattar, N.; Seferović, P.M.; Sousa-Uva, M.; Valensi, P.; Wheeler, D.C.; Piepoli, M.F.; Birkeland, K.I.; Adamopoulos, S.; Ajjan, R.; Avogaro, A.; Baigent, C.; Brodmann, M.; Bueno, H.; Ceconi, C.; Chioncel, O.; Coats, A.; Collet, J-P.; Collins, P.; Cosyns, B.; Di Mario, C.; Fisher, M.; Fitzsimons, D.; Halvorsen, S.; Hansen, D.; Hoes, A.; Holt, R.I.G.; Home, P.; Katus, H.A.; Khunti, K.; Komajda, M.; Lambrinou, E.; Landmesser, U.; Lewis, B.S.; Linde, C.; Lorusso, R.; Mach, F.; Mueller, C.; Neumann, F-J.; Persson, F.; Petersen, S.E.; Petronio, A.S.; Richter, D.J.; Rosano, G.M.C.; Rossing, P.; Rydén, L.; Shlyakhto, E.; Simpson, I.A.; Touyz, R.M.; Wijns, W.; Wilhelm, M.; Williams, B.; Aboyans, V.; Bailey, C.J.; Ceriello, A.; Delgado, V.; Federici, M.; Filippatos, G.; Grobbee, D.E.; Hansen, T.B.; Huikuri, H.V.; Johansson, I.; Jüni, P.; Lettino, M.; Marx, N.; Mellbin, L.G.; Östgren, C.J.; Rocca, B.; Roffi, M.; Sattar, N.; Seferović, P.M.; Sousa-Uva, M.; Valensi, P.; Wheeler, D.C.; Windecker, S.; Aboyans, V.; Baigent, C.; Collet, J-P.; Dean, V.; Delgado, V.; Fitzsimons, D.; Gale, C.P.; Grobbee, D.E.; Halvorsen, S.; Hindricks, G.; Iung, B.; Jüni, P.; Katus, H.A.; Landmesser, U.; Leclercq, C.; Lettino, M.; Lewis, B.S.; Merkely, B.; Mueller, C.; Petersen, S.E.; Petronio, A.S.; Richter, D.J.; Roffi, M.; Shlyakhto, E.; Simpson, I.A.; Sousa-Uva, M.; Touyz, R.M.; Zelveian, P.H.; Scherr, D.; Jahangirov, T.; Lazareva, I.; Shivalkar, B.; Naser, N.; Gruev, I.; Milicic, D.; Petrou, P.M.; Linhart, A.; Hildebrandt, P.; Hasan-Ali, H.; Marandi, T.; Lehto, S.; Mansourati, J.; Kurashvili, R.; Siasos, G.; Lengyel, C.; Thrainsdottir, I.S.; Aronson, D.; Di Lenarda, A.; Raissova, A.; Ibrahimi, P.; Abilova, S.; Trusinskis, K.; Saade, G.; Benlamin, H.; Petrulioniene, Z.; Banu, C.; Magri, C.J.; David, L.; Boskovic, A.; Alami, M.; Liem, A.H.; Bosevski, M.; Svingen, G.F.T.; Janion, M.; Gavina, C.; Vinereanu, D.; Nedogoda, S.; Mancini, T.; Ilic, M.D.; Fabryova, L.; Fras, Z.; Navarro, J.M.F.; Norhammar, A.; Lehmann, R.; Mourali, M.S.; Ural, D.; Nesukay, E.; Chowdhury, T.A. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J., 2020, 41(2), 255-323.
[http://dx.doi.org/10.1093/eurheartj/ehz486] [PMID: 31497854]

Zidek, W.; Schrader, J.; Lüders, S.; Matthaei, S.; Hasslacher, C.; Hoyer, J.; Zemmrich, C.; Bramlage, P.; Sturm, C.D.; Paar, W.D. Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study. Cardiovasc. Diabetol., 2012, 11(1), 1.
[http://dx.doi.org/10.1186/1475-2840-11-1] [PMID: 22230104]

Nazarzadeh, M.; Bidel, Z.; Canoy, D.; Copland, E.; Wamil, M.; Majert, J.; Smith Byrne, K.; Sundström, J.; Teo, K.; Davis, B.R.; Chalmers, J.; Pepine, C.J.; Dehghan, A.; Bennett, D.A.; Smith, G.D.; Rahimi, K. Blood pressure lowering and risk of new-onset type 2 diabetes: An individual participant data meta-analysis. Lancet, 2021, 398(10313), 1803-1810.
[http://dx.doi.org/10.1016/S0140-6736(21)01920-6] [PMID: 34774144]

Feingold, K.R. Obesity and Dyslipidemia, 2000. MDText.com, Inc., South Dartmouth (MA), Available from: https://europepmc.org/article/NBK/nbk305895

Grundy, S.M.; Arai, H.; Barter, P.; Bersot, T.P.; Betteridge, D.J.; Carmena, R.; Cuevas, A.; Davidson, M.H.; Genest, J.; Kesäniemi, Y.A.; Sadikot, S.; Santos, R.D.; Susekov, A.; Sy, R.; Tokgozoglu, L.; Watts, G.F.; Zhao, D. An international atherosclerosis society position paper: Global recommendations for the management of dyslipidemia: Executive summary. Atherosclerosis, 2014, 232(2), 410-413.
[http://dx.doi.org/10.1016/j.atherosclerosis.2013.11.031] [PMID: 24468156]

Grundy, S.M.; Stone, N.J.; Bailey, A.L.; Beam, C.; Birtcher, K.K.; Blumenthal, R.S.; Braun, L.T.; de Ferranti, S.; Tommasino, F.J.; Forman, D.E.; Goldberg, R.; Heidenreich, P.A.; Hlatky, M.A.; Jones, D.W.; Jones, L.D.; Pajares, L.N.; Ndumele, C.E.; Orringer, C.E.; Peralta, C.A.; Saseen, J.J.; Smith, S.C., Jr; Sperling, L.; Virani, S.S.; Yeboah, J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation, 2019, 139(25), e1082-e1143.
[PMID: 30586774]

Jellinger, P.S.; Handelsman, Y.; Rosenblit, P.D.; Bloomgarden, Z.T.; Fonseca, V.A.; Garber, A.J.; Grunberger, G.; Guerin, C.K.; Bell, D.S.H.; Mechanick, J.I.; Pessah-Pollack, R.; Wyne, K.; Smith, D.; Brinton, E.A.; Fazio, S.; Davidson, M.; Jellinger, P.S.; Handelsman, Y.; Bell, D.S.H.; Bloomgarden, Z.T.; Brinton, E.A.; Davidson, M.H.; Fazio, S.; Fonseca, V.A.; Garber, A.J.; Grunberger, G.; Guerin, C.K.; Mechanick, J.I.; Pessah-Pollack, R.; Rosenblit, P.D.; Smith, D.A.; Wyne, K.; Bush, M.; Zangeneh, F.; Handelsman, Y.; Bell, D.S.H.; Bloomgarden, Z.T.; Brinton, E.A.; Fazio, S.; Fonseca, V.A.; Garber, A.J.; Grunberger, G.; Guerin, C.K.; Jellinger, P.S.; Rosenblit, P.D.; Smith, D.A.; Wyne, K.; Davidson, M.H. American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr. Pract., 2017, 23(S1), 1-87.
[http://dx.doi.org/10.4158/EP171764.APPGL] [PMID: 28437620]

Mach, F.; Baigent, C.; Catapano, A.L.; Koskinas, K.C.; Casula, M.; Badimon, L.; Chapman, M.J.; De Backer, G.G.; Delgado, V.; Ference, B.A.; Graham, I.M.; Halliday, A.; Landmesser, U.; Mihaylova, B.; Pedersen, T.R.; Riccardi, G.; Richter, D.J.; Sabatine, M.S.; Taskinen, M.R.; Tokgozoglu, L.; Wiklund, O.; Mueller, C.; Drexel, H.; Aboyans, V.; Corsini, A.; Doehner, W.; Farnier, M.; Gigante, B.; Kayikcioglu, M.; Krstacic, G.; Lambrinou, E.; Lewis, B.S.; Masip, J.; Moulin, P.; Petersen, S.; Petronio, A.S.; Piepoli, M.F.; Pintó, X.; Räber, L.; Ray, K.K.; Reiner, Ž.; Riesen, W.F.; Roffi, M.; Schmid, J-P.; Shlyakhto, E.; Simpson, I.A.; Stroes, E.; Sudano, I.; Tselepis, A.D.; Viigimaa, M.; Vindis, C.; Vonbank, A.; Vrablik, M.; Vrsalovic, M.; Zamorano, J.L.; Collet, J-P.; Koskinas, K.C.; Casula, M.; Badimon, L.; John Chapman, M.; De Backer, G.G.; Delgado, V.; Ference, B.A.; Graham, I.M.; Halliday, A.; Landmesser, U.; Mihaylova, B.; Pedersen, T.R.; Riccardi, G.; Richter, D.J.; Sabatine, M.S.; Taskinen, M-R.; Tokgozoglu, L.; Wiklund, O.; Windecker, S.; Aboyans, V.; Baigent, C.; Collet, J-P.; Dean, V.; Delgado, V.; Fitzsimons, D.; Gale, C.P.; Grobbee, D.; Halvorsen, S.; Hindricks, G.; Iung, B.; Jüni, P.; Katus, H.A.; Landmesser, U.; Leclercq, C.; Lettino, M.; Lewis, B.S.; Merkely, B.; Mueller, C.; Petersen, S.; Petronio, A.S.; Richter, D.J.; Roffi, M.; Shlyakhto, E.; Simpson, I.A.; Sousa-Uva, M.; Touyz, R.M.; Nibouche, D.; Zelveian, P.H.; Siostrzonek, P.; Najafov, R.; van de Borne, P.; Pojskic, B.; Postadzhiyan, A.; Kypris, L.; Špinar, J.; Larsen, M.L.; Eldin, H.S.; Viigimaa, M.; Strandberg, T.E.; Ferrières, J.; Agladze, R.; Laufs, U.; Rallidis, L.; Bajnok, L.; Gudjónsson, T.; Maher, V.; Henkin, Y.; Gulizia, M.M.; Mussagaliyeva, A.; Bajraktari, G.; Kerimkulova, A.; Latkovskis, G.; Hamoui, O.; Slapikas, R.; Visser, L.; Dingli, P.; Ivanov, V.; Boskovic, A.; Nazzi, M.; Visseren, F.; Mitevska, I.; Retterstøl, K.; Jankowski, P.; Fontes-Carvalho, R.; Gaita, D.; Ezhov, M.; Foscoli, M.; Giga, V.; Pella, D.; Fras, Z.; de Isla, L.P.; Hagström, E.; Lehmann, R.; Abid, L.; Ozdogan, O.; Mitchenko, O.; Patel, R.S. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J., 2020, 41(1), 111-188.
[http://dx.doi.org/10.1093/eurheartj/ehz455] [PMID: 31504418]

Jacobson, T.A.; Ito, M.K.; Maki, K.C.; Orringer, C.E.; Bays, H.E.; Jones, P.H.; McKenney, J.M.; Grundy, S.M.; Gill, E.A.; Wild, R.A.; Wilson, D.P.; Brown, W.V. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary. J. Clin. Lipidol., 2014, 8(5), 473-488.
[http://dx.doi.org/10.1016/j.jacl.2014.07.007] [PMID: 25234560]

Handelsman, Y.; Jellinger, P.S.; Guerin, C.K.; Bloomgarden, Z.T.; Brinton, E.A.; Budoff, M.J.; Davidson, M.H.; Einhorn, D.; Fazio, S.; Fonseca, V.A.; Garber, A.J.; Grunberger, G.; Krauss, R.M.; Mechanick, J.I.; Rosenblit, P.D.; Smith, D.A.; Wyne, K.L. Consensus statement by the America Association of Clinical Endocrinologists and American College of Endocrinology on the management of dyslipidemia and prevention cardiovascular disease algorithm – 2020 – Executive summary. Endocr. Pract., 2020, 26(10), 1196-1224.
[http://dx.doi.org/10.4158/CS-2020-0490] [PMID: 33471721]

Berglund, L.; Brunzell, J.D.; Goldberg, A.C.; Goldberg, I.J.; Sacks, F.; Murad, M.H.; Stalenhoef, A.F.H. Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab., 2012, 97(9), 2969-2989.
[http://dx.doi.org/10.1210/jc.2011-3213] [PMID: 22962670]

US Food and Drug Administration (FDA). FDA drug safety communication: Important safety label changes to cholesterol-lowering statin drugs. Available from: http://www.fda.gov/drugs/drugsafety/ucm293101.htm

Ponziani, M.C.; Karamouzis, I.; Mele, C.; Chasseur, L.; Zavattaro, M.; Caputo, M.; Samà, M.T.; Busti, A.; Pagano, L.; Castello, L.; Marzullo, P.; Aimaretti, G.; Prodam, F. Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life. Hormones, 2017, 16(4), 396-404.
[PMID: 29518760]

Guber, K.; Pemmasani, G.; Malik, A.; Aronow, W.S.; Yandrapalli, S.; Frishman, W.H. Statins and higher diabetes mellitus risk: Incidence, proposed mechanisms, and clinical implications. Cardiol. Rev., 2021, 29(6), 314-322.
[http://dx.doi.org/10.1097/CRD.0000000000000348] [PMID: 32947479]

Rajpathak, S.N.; Kumbhani, D.J.; Crandall, J.; Barzilai, N.; Alderman, M.; Ridker, P.M. Statin therapy and risk of developing type 2 diabetes: A meta-analysis. Diabetes Care, 2009, 32(10), 1924-1929.
[http://dx.doi.org/10.2337/dc09-0738] [PMID: 19794004]

Sattar, N.; Preiss, D.; Murray, H.M.; Welsh, P.; Buckley, B.M.; de Craen, A.J.M.; Seshasai, S.R.K.; McMurray, J.J.; Freeman, D.J.; Jukema, J.W.; Macfarlane, P.W.; Packard, C.J.; Stott, D.J.; Westendorp, R.G.; Shepherd, J.; Davis, B.R.; Pressel, S.L.; Marchioli, R.; Marfisi, R.M.; Maggioni, A.P.; Tavazzi, L.; Tognoni, G.; Kjekshus, J.; Pedersen, T.R.; Cook, T.J.; Gotto, A.M.; Clearfield, M.B.; Downs, J.R.; Nakamura, H.; Ohashi, Y.; Mizuno, K.; Ray, K.K.; Ford, I. Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. Lancet, 2010, 375(9716), 735-742.
[http://dx.doi.org/10.1016/S0140-6736(09)61965-6] [PMID: 20167359]

Preiss, D.; Seshasai, S.R.; Welsh, P.; Murphy, S.A.; Ho, J.E.; Waters, D.D.; DeMicco, D.A.; Barter, P.; Cannon, C.P.; Sabatine, M.S.; Braunwald, E.; Kastelein, J.J.; de Lemos, J.A.; Blazing, M.A.; Pedersen, T.R.; Tikkanen, M.J.; Sattar, N.; Ray, K.K. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis. JAMA, 2011, 305(24), 2556-2564.
[http://dx.doi.org/10.1001/jama.2011.860] [PMID: 21693744]

Seo, W.W.; Seo, S.I.; Kim, Y.; Yoo, J.J.; Shin, W.G.; Kim, J.; You, S.C.; Park, R.W.; Park, Y.M.; Kim, K.J.; Rhee, S.Y.; Park, M.; Jin, E.S.; Kim, S.E. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: A distributed network analysis of 10 real-world databases. Cardiovasc. Diabetol., 2022, 21(1), 82.
[http://dx.doi.org/10.1186/s12933-022-01524-6] [PMID: 35606846]

Brault, M.; Ray, J.; Gomez, Y.H.; Mantzoros, C.S.; Daskalopoulou, S.S. Statin treatment and new-onset diabetes: A review of proposed mechanisms. Metabolism, 2014, 63(6), 735-745.
[http://dx.doi.org/10.1016/j.metabol.2014.02.014] [PMID: 24641882]

Zhao, S.P.; Zhao, W. Different effects of statins on induction of diabetes mellitus: An experimental study. Drug Des. Devel. Ther., 2015, 9, 6211-6223.
[http://dx.doi.org/10.2147/DDDT.S87979] [PMID: 26648697]

Nomura, S.; Shouzu, A.; Omoto, S.; Inami, N.; Tanaka, A.; Nanba, M.; Shouda, Y.; Takahashi, N.; Kimura, Y.; Iwasaka, T. Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus. Thromb. Res., 2008, 122(1), 39-45.
[http://dx.doi.org/10.1016/j.thromres.2007.08.013] [PMID: 17920663]

Chruściel, P.; Sahebkar, A.; Wieliczko, R.M.; Serban, M.C.; Ursoniu, S.; Mikhailidis, D.P.; Jones, S.R.; Mosteoru, S.; Blaha, M.J.; Martin, S.S.; Rysz, J.; Toth, P.P.; Lip, G.Y.H.; Pencina, M.J.; Ray, K.K.; Banach, M. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis, 2016, 253, 194-208.
[http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.897] [PMID: 27498397]

Rinella, M.E.; Lazarus, J.V.; Ratziu, V.; Francque, S.M.; Sanyal, A.J.; Kanwal, F.; Romero, D.; Abdelmalek, M.F.; Anstee, Q.M.; Arab, J.P.; Arrese, M.; Bataller, R.; Beuers, U.; Boursier, J.; Bugianesi, E.; Byrne, C.D.; Castro Narro, G.E.; Chowdhury, A.; Cortez-Pinto, H.; Cryer, D.R.; Cusi, K.; El-Kassas, M.; Klein, S.; Eskridge, W.; Fan, J.; Gawrieh, S.; Guy, C.D.; Harrison, S.A.; Kim, S.U.; Koot, B.G.; Korenjak, M.; Kowdley, K.V.; Lacaille, F.; Loomba, R.; Mitchell-Thain, R.; Morgan, T.R.; Powell, E.E.; Roden, M.; Romero-Gómez, M.; Silva, M.; Singh, S.P.; Sookoian, S.C.; Spearman, C.W.; Tiniakos, D.; Valenti, L.; Vos, M.B.; Wong, V.W.S.; Xanthakos, S.; Yilmaz, Y.; Younossi, Z.; Hobbs, A.; Rivas, V.M.; Newsome, P.N. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 2023, 78(6), 1966-1986.
[http://dx.doi.org/10.1097/HEP.0000000000000520] [PMID: 37363821]

EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 2016, 64(6), 1388-1402.
[http://dx.doi.org/10.1016/j.jhep.2015.11.004]

Powell, E.E.; Wong, V.W.S.; Rinella, M. Non-alcoholic fatty liver disease. Lancet, 2021, 397(10290), 2212-2224.
[http://dx.doi.org/10.1016/S0140-6736(20)32511-3] [PMID: 33894145]

Chalasani, N.; Younossi, Z.; Lavine, J.E.; Charlton, M.; Cusi, K.; Rinella, M.; Harrison, S.A.; Brunt, E.M.; Sanyal, A.J. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 2018, 67(1), 328-357.
[http://dx.doi.org/10.1002/hep.29367] [PMID: 28714183]

Wong, C.R.; Lim, J.K. The association between nonalcoholic fatty liver disease and cardiovascular disease outcomes. Clin. Liver Dis., 2018, 12(2), 39-44.
[http://dx.doi.org/10.1002/cld.721] [PMID: 30988909]

Kanwal, F.; Shubrook, J.H.; Younossi, Z.; Natarajan, Y.; Bugianesi, E.; Rinella, M.E.; Harrison, S.A.; Mantzoros, C.; Pfotenhauer, K.; Klein, S.; Eckel, R.H.; Kruger, D.; El-Serag, H.; Cusi, K. Preparing for the NASH epidemic: A call to action. Diabetes Care, 2021, 44(9), 2162-2172.
[http://dx.doi.org/10.2337/dci21-0020] [PMID: 34312182]

Taharboucht, S.; Guermaz, R.; Brouri, M.; Chibane, A. Pre-diabetes and NAFLD; A study of an Algerian population sample. Endocr. Metabol. Sci., 2020, 1(3-4), 100060.
[http://dx.doi.org/10.1016/j.endmts.2020.100060]

Targher, G.; Corey, K.E.; Byrne, C.D.; Roden, M. The complex link between NAFLD and type 2 diabetes mellitus — Mechanisms and treatments. Nat. Rev. Gastroenterol. Hepatol., 2021, 18(9), 599-612.
[http://dx.doi.org/10.1038/s41575-021-00448-y] [PMID: 33972770]

Park, J.; Kwon, H.J.; Sohn, W.; Cho, J.Y.; Park, S.J.; Chang, Y.; Ryu, S.; Kim, B.I.; Cho, Y.K. Risk of liver fibrosis in patients with prediabetes and diabetes mellitus. PLoS One, 2022, 17(6), e0269070.
[http://dx.doi.org/10.1371/journal.pone.0269070] [PMID: 35653399]

Souto, K.P.; Meinhardt, N.G.; Ramos, M.J.; Ulbrich-Kulkzynski, J.M.; Stein, A.T.; Damin, D.C. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: Analysis of intraoperative liver biopsies and literature review. Surg. Obes. Relat. Dis., 2018, 14(1), 66-73.
[http://dx.doi.org/10.1016/j.soard.2017.09.527] [PMID: 29104004]

Wong, V.W.S.; Adams, L.A.; de Lédinghen, V.; Wong, G.L.H.; Sookoian, S. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise. Nat. Rev. Gastroenterol. Hepatol., 2018, 15(8), 461-478.
[http://dx.doi.org/10.1038/s41575-018-0014-9] [PMID: 29844588]

Caussy, C.; Reeder, S.B.; Sirlin, C.B.; Loomba, R. Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology, 2018, 68(2), 763-772.
[http://dx.doi.org/10.1002/hep.29797] [PMID: 29356032]

Berzigotti, A.; Tsochatzis, E.; Boursier, J.; Castera, L.; Cazzagon, N.; Rust, F.M.; Petta, S.; Thiele, M. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J. Hepatol., 2021, 75(3), 659-689.
[http://dx.doi.org/10.1016/j.jhep.2021.05.025] [PMID: 34166721]

Wong, V.W.S.; Wong, G.L.H.; Tsang, S.W.C.; Hui, A.Y.; Chan, A.W.H.; Choi, P.C.L.; Chim, A.M.L.; Chu, S.; Chan, F.K.L.; Sung, J.J.Y.; Chan, H.L.Y. Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment. Pharmacol. Ther., 2009, 29(4), 387-396.
[http://dx.doi.org/10.1111/j.1365-2036.2008.03896.x] [PMID: 19035982]

Ratziu, V.; Charlotte, F.; Heurtier, A.; Gombert, S.; Giral, P.; Bruckert, E.; Grimaldi, A.; Capron, F.; Poynard, T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology, 2005, 128(7), 1898-1906.
[http://dx.doi.org/10.1053/j.gastro.2005.03.084] [PMID: 15940625]

Bedossa, P.; Consortium, F.P. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology, 2014, 60(2), 565-575.
[http://dx.doi.org/10.1002/hep.27173] [PMID: 24753132]

Davison, B.A.; Harrison, S.A.; Cotter, G.; Alkhouri, N.; Sanyal, A.; Edwards, C.; Colca, J.R.; Iwashita, J.; Koch, G.G.; Dittrich, H.C. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J. Hepatol., 2020, 73(6), 1322-1332.
[http://dx.doi.org/10.1016/j.jhep.2020.06.025] [PMID: 32610115]

EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol., 2015, 63(1), 237-264.
[http://dx.doi.org/10.1016/j.jhep.2015.04.006] [PMID: 25911335]

Mahady, S.E.; Macaskill, P.; Craig, J.C.; Wong, G.L.H.; Chu, W.C.W.; Chan, H.L.Y.; George, J.; Wong, V.W.S. Diagnostic accuracy of noninvasive fibrosis scores in a population of individuals with a low prevalence of fibrosis. Clin. Gastroenterol. Hepatol., 2017, 15(9), 1453-1460.e1.
[http://dx.doi.org/10.1016/j.cgh.2017.02.031] [PMID: 28286195]

Hagström, H.; Talbäck, M.; Andreasson, A.; Walldius, G.; Hammar, N. Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease. Gastroenterology, 2020, 158(1), 200-214.
[http://dx.doi.org/10.1053/j.gastro.2019.09.008] [PMID: 31563624]

Cusi, K.; Orsak, B.; Bril, F.; Lomonaco, R.; Hecht, J.; Lopez, O.C.; Tio, F.; Hardies, J.; Darland, C.; Musi, N.; Webb, A.; Sanchez, P.P. Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: A randomized trial. Ann. Intern. Med., 2016, 165(5), 305-315.
[http://dx.doi.org/10.7326/M15-1774] [PMID: 27322798]

Lian, J.; Fu, J. Pioglitazone for NAFLD patients with prediabetes or type 2 diabetes mellitus: A meta-analysis. Front. Endocrinol., 2021, 12, 615409.
[http://dx.doi.org/10.3389/fendo.2021.615409] [PMID: 33995271]

Lian, J.; Fu, J. Efficacy of various hypoglycemic agents in the treatment of patients with nonalcoholic liver disease with or without diabetes: A network meta-analysis. Front. Endocrinol., 2021, 12, 649018.
[http://dx.doi.org/10.3389/fendo.2021.649018] [PMID: 33841337]

Taheri, H.; Malek, M.; Beigi, I.F.; Zamani, F.; Sohrabi, M.; babaei, R.M.; Khamseh, M.E. Effect of empagliflozin on liver steatosis and fibrosis in patients with non-alcoholic fatty liver disease without diabetes: A randomized, double-blind, placebo-controlled trial. Adv. Ther., 2020, 37(11), 4697-4708.
[http://dx.doi.org/10.1007/s12325-020-01498-5] [PMID: 32975679]

Cheng, S.; Ge, J.; Zhao, C.; Le, S.; Yang, Y.; Ke, D.; Wu, N.; Tan, X.; Zhang, X.; Du, X.; Sun, J.; Wang, R.; Shi, Y.; Borra, R.J.H.; Parkkola, R.; Wiklund, P.; Lu, D. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial. Sci. Rep., 2017, 7(1), 15952.
[http://dx.doi.org/10.1038/s41598-017-16159-x] [PMID: 29162875]

Sheka, A.C.; Adeyi, O.; Thompson, J.; Hameed, B.; Crawford, P.A.; Ikramuddin, S. Nonalcoholic steatohepatitis. JAMA, 2020, 323(12), 1175-1183.
[http://dx.doi.org/10.1001/jama.2020.2298] [PMID: 32207804]

Eguchi, Y.; Wong, G.; Lee, E.I.H.; Akhtar, O.; Lopes, R.; Sumida, Y. Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review. JGH Open, 2020, 4(5), 808-817.
[http://dx.doi.org/10.1002/jgh3.12349] [PMID: 33102749]

Cusi, K.; Isaacs, S.; Barb, D.; Basu, R.; Caprio, S.; Garvey, W.T.; Kashyap, S.; Mechanick, J.I.; Mouzaki, M.; Nadolsky, K.; Rinella, M.E. Guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-sponsored by the american association for the study of liver diseases (AASLD). Endocr. Pract., 2022, 28(5), 528-562.
[http://dx.doi.org/10.1016/j.eprac.2022.03.010] [PMID: 35569886]

Wong, V.W.S.; Chan, W.K.; Chitturi, S.; Chawla, Y.; Dan, Y.Y.; Duseja, A.; Fan, J.; Goh, K.L.; Hamaguchi, M.; Hashimoto, E.; Kim, S.U.; Lesmana, L.A.; Lin, Y.C.; Liu, C.J.; Ni, Y.H.; Sollano, J.; Wong, S.K.H.; Wong, G.L.H.; Chan, H.L.Y.; Farrell, G. Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017—part 1: Definition, risk factors and assessment. J. Gastroenterol. Hepatol., 2018, 33(1), 70-85.
[http://dx.doi.org/10.1111/jgh.13857] [PMID: 28670712]

ElSayed, N.A.; Aleppo, G.; Aroda, V.R.; Bannuru, R.R.; Brown, F.M.; Bruemmer, D.; Collins, B.S.; Cusi, K.; Hilliard, M.E.; Isaacs, D.; Johnson, E.L.; Kahan, S.; Khunti, K.; Leon, J.; Lyons, S.K.; Perry, M.L.; Prahalad, P.; Pratley, R.E.; Seley, J.J.; Stanton, R.C.; Younossi, Z.; Gabbay, R.A. 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of care in diabetes—2023. Diabetes Care, 2023, 46(S1), s49-, s67.2.
[http://dx.doi.org/10.2337/dc23-S004] [PMID: 36507651]